<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Toxics</journal-id><journal-id journal-id-type="iso-abbrev">Toxics</journal-id><journal-id journal-id-type="publisher-id">toxics</journal-id><journal-title-group><journal-title>Toxics</journal-title></journal-title-group><issn pub-type="epub">2305-6304</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39997897</article-id><article-id pub-id-type="pmc">PMC11861298</article-id>
<article-id pub-id-type="doi">10.3390/toxics13020081</article-id><article-id pub-id-type="publisher-id">toxics-13-00081</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Albuminuria in People Chronically Exposed to Low-Dose Cadmium Is Linked to Rising Blood Pressure Levels</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Satarug</surname><given-names>Soisungwan</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><xref rid="af1-toxics-13-00081" ref-type="aff">1</xref><xref rid="c1-toxics-13-00081" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1638-4227</contrib-id><name><surname>Yimthiang</surname><given-names>Supabhorn</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af2-toxics-13-00081" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Khamphaya</surname><given-names>Tanaporn</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af2-toxics-13-00081" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Pouyfung</surname><given-names>Phisit</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af3-toxics-13-00081" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2856-6650</contrib-id><name><surname>Vesey</surname><given-names>David A.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><xref rid="af1-toxics-13-00081" ref-type="aff">1</xref><xref rid="af4-toxics-13-00081" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6942-7040</contrib-id><name><surname>Buha &#x00110;or&#x00111;evi&#x00107;</surname><given-names>Aleksandra</given-names></name><xref rid="af5-toxics-13-00081" ref-type="aff">5</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Vanoirbeek</surname><given-names>Jeroen</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-toxics-13-00081"><label>1</label>Centre for Kidney Disease Research, Translational Research Institute, Woolloongabba, Brisbane, QLD 4102, Australia; <email>david.vesey@health.qld.gov.au</email></aff><aff id="af2-toxics-13-00081"><label>2</label>Occupational Health and Safety, School of Public Health, Walailak University, Nakhon Si Thammarat 80160, Thailand; <email>ksupapor@mail.wu.ac.th</email> (S.Y.); <email>tanaporn.kh@mail.wu.ac.th</email> (T.K.)</aff><aff id="af3-toxics-13-00081"><label>3</label>Department of Community Health, Faculty of Public Health, Mahidol University, Bangkok 20100, Thailand; <email>phisit.pou@mahidol.edu</email></aff><aff id="af4-toxics-13-00081"><label>4</label>Department of Kidney and Transplant Services, Princess Alexandra Hospital, Brisbane, QLD 4102, Australia</aff><aff id="af5-toxics-13-00081"><label>5</label>Department of Toxicology &#x0201c;Akademik Danilo Soldatovi&#x00107;&#x0201d;, University of Belgrade-Faculty of Pharmacy, 11000 Belgrade, Serbia; <email>aleksandra.buha@pharmacy.bg.ac.rs</email></aff><author-notes><corresp id="c1-toxics-13-00081"><label>*</label>Correspondence: <email>sj.satarug@yahoo.com.au</email></corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>13</volume><issue>2</issue><elocation-id>81</elocation-id><history><date date-type="received"><day>31</day><month>12</month><year>2024</year></date><date date-type="rev-recd"><day>18</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>23</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Exposure to low-dose environmental pollutant cadmium (Cd) increases the risks of both albuminuria and hypertension by mechanisms which are poorly understood. Here, multiple regression and mediation analyses were applied to data from 641 Thai subjects of whom 39.8%, 16.5%, 10.8%, and 4.8% had hypertension, albuminuria, diabetes, and chronic kidney disease (CKD), defined as the estimated glomerular filtration rate (eGFR) &#x02264; 60 mL/min/1.73 m<sup>2</sup>, respectively. To correct for interindividual differences in urine dilution and surviving nephrons, the excretion rates of Cd (E<sub>Cd</sub>), albumin (E<sub>alb</sub>), and &#x003b2;<sub>2</sub>-microglobulin (E<sub>&#x003b2;2M</sub>) were normalized to the creatinine clearance (C<sub>cr</sub>) as E<sub>Cd</sub>/C<sub>cr</sub>, E<sub>alb</sub>/C<sub>cr</sub>, and E<sub>&#x003b2;2M</sub>/C<sub>cr</sub>. The respective risks of having CKD and hypertension rose to 3.52 (95% CI: 1.75, 7.05) and 1.22 (95% CI: 1.12, 1.3) per doubling of the Cd body burden. The respective risk of having albuminuria increased 2.95-fold (<italic toggle="yes">p</italic> = 0.042) and 4.17-fold (<italic toggle="yes">p</italic> = 0.020) in subjects who had hypertension plus severe and extremely severe tubular dysfunction, defined according to the elevated &#x003b2;<sub>2</sub>M excretion rates. In multiple regression analysis, the E<sub>alb</sub>/C<sub>cr</sub> increased linearly with both the systolic blood pressure (SBP, &#x003b2; = 0.263) and diastolic blood pressure (DBP, &#x003b2; = 0.150), while showing an inverse association with eGFR (&#x003b2; = &#x02212;0.180). The mediation model analyses inferred that a declining eGFR induced by Cd contributed to 80.6% of the SBP increment (<italic toggle="yes">p</italic> = 0.005), which then fully mediated an elevation of albumin excretion (<italic toggle="yes">p</italic> &#x0003c; 0.001). The present study provides, for the first time, evidence that causally links Cd-induced eGFR reductions to blood pressure elevations, which enhance albumin excretion.</p></abstract><kwd-group><kwd>albuminuria</kwd><kwd>blood pressure</kwd><kwd>&#x003b2;<sub>2</sub>-microglobulin</kwd><kwd>cadmium</kwd><kwd>estimated glomerular filtration rate</kwd><kwd>mediation analysis</kwd></kwd-group><funding-group><funding-statement>This research received no external funding.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-toxics-13-00081"><title>1. Introduction</title><p>Approximately 8&#x02013;13% of the world&#x02019;s population lives with chronic kidney disease (CKD) [<xref rid="B1-toxics-13-00081" ref-type="bibr">1</xref>,<xref rid="B2-toxics-13-00081" ref-type="bibr">2</xref>,<xref rid="B3-toxics-13-00081" ref-type="bibr">3</xref>]. CKD is predicted to become the fifth leading cause of years of life lost by 2040 [<xref rid="B4-toxics-13-00081" ref-type="bibr">4</xref>,<xref rid="B5-toxics-13-00081" ref-type="bibr">5</xref>]. In the early stages, CKD is asymptomatic, and it is diagnosed when there is a substantial loss of functioning nephrons, evident from a fall in the estimated glomerular filtration rate (eGFR) below 60 mL/min/1.73 m<sup>2</sup> (termed low eGFR) [<xref rid="B1-toxics-13-00081" ref-type="bibr">1</xref>,<xref rid="B2-toxics-13-00081" ref-type="bibr">2</xref>,<xref rid="B3-toxics-13-00081" ref-type="bibr">3</xref>]. This CKD diagnostic stage often co-exists with disease comorbidities such as hypertension and proteinuria [<xref rid="B2-toxics-13-00081" ref-type="bibr">2</xref>]. Albuminuria that persists for at least 3 months is also a CKD diagnostic criterion [<xref rid="B1-toxics-13-00081" ref-type="bibr">1</xref>,<xref rid="B2-toxics-13-00081" ref-type="bibr">2</xref>,<xref rid="B3-toxics-13-00081" ref-type="bibr">3</xref>]. Albuminuria is designated, when the excretion of albumin (E<sub>alb</sub>), typically measured as the albumin-to-creatinine ratio (ACR), rises to levels above 20 and 30 mg/g creatinine in men and women, respectively [<xref rid="B1-toxics-13-00081" ref-type="bibr">1</xref>,<xref rid="B2-toxics-13-00081" ref-type="bibr">2</xref>,<xref rid="B3-toxics-13-00081" ref-type="bibr">3</xref>].</p><p>Elevated risks of kidney damage [<xref rid="B6-toxics-13-00081" ref-type="bibr">6</xref>,<xref rid="B7-toxics-13-00081" ref-type="bibr">7</xref>,<xref rid="B8-toxics-13-00081" ref-type="bibr">8</xref>], albuminuria [<xref rid="B9-toxics-13-00081" ref-type="bibr">9</xref>,<xref rid="B10-toxics-13-00081" ref-type="bibr">10</xref>,<xref rid="B11-toxics-13-00081" ref-type="bibr">11</xref>], proteinuria [<xref rid="B12-toxics-13-00081" ref-type="bibr">12</xref>,<xref rid="B13-toxics-13-00081" ref-type="bibr">13</xref>], and CKD [<xref rid="B14-toxics-13-00081" ref-type="bibr">14</xref>,<xref rid="B15-toxics-13-00081" ref-type="bibr">15</xref>,<xref rid="B16-toxics-13-00081" ref-type="bibr">16</xref>,<xref rid="B17-toxics-13-00081" ref-type="bibr">17</xref>] have repeatedly been linked to chronic exposure to the metal pollutant cadmium (Cd) in many countries. There is also an increased mortality risk among CKD patients who had an elevated Cd body burden, reflected by Cd excretion rates &#x02265; 0.60 &#x003bc;g/g creatinine [<xref rid="B18-toxics-13-00081" ref-type="bibr">18</xref>].</p><p>Cd is a metal contaminant with no nutritional value or physiological role, and it presents worldwide public health concerns because it is highly toxic [<xref rid="B19-toxics-13-00081" ref-type="bibr">19</xref>]. For most people, exposure to Cd is unavoidable because it is found in most food types [<xref rid="B20-toxics-13-00081" ref-type="bibr">20</xref>,<xref rid="B21-toxics-13-00081" ref-type="bibr">21</xref>,<xref rid="B22-toxics-13-00081" ref-type="bibr">22</xref>], cigarette smoke, and polluted air [<xref rid="B23-toxics-13-00081" ref-type="bibr">23</xref>,<xref rid="B24-toxics-13-00081" ref-type="bibr">24</xref>,<xref rid="B25-toxics-13-00081" ref-type="bibr">25</xref>]. Most acquired Cd accumulates within the kidney tubular cells, where its levels increase through to the age of 50 years but decline thereafter, due to its release into the urine, as the injured tubular cells die [<xref rid="B19-toxics-13-00081" ref-type="bibr">19</xref>,<xref rid="B26-toxics-13-00081" ref-type="bibr">26</xref>]. Because most or all excreted Cd emanates from injured or dying tubular cells, excretion of Cd reflects the injury at the present time, not the risk of injury in the future [<xref rid="B25-toxics-13-00081" ref-type="bibr">25</xref>,<xref rid="B26-toxics-13-00081" ref-type="bibr">26</xref>].</p><p>Kidney tubular cell damage and tubular dysfunction, indicated by an increased excretion of the low-molecular weight protein, &#x003b2;<sub>2</sub>-microglobulin (&#x003b2;<sub>2</sub>M), are the most frequently reported adverse effects of Cd exposure [<xref rid="B25-toxics-13-00081" ref-type="bibr">25</xref>]. An increase in &#x003b2;<sub>2</sub>M excretion above 300 &#x000b5;g/g creatinine was used in the toxicological risk assessment of dietary Cd [<xref rid="B27-toxics-13-00081" ref-type="bibr">27</xref>,<xref rid="B28-toxics-13-00081" ref-type="bibr">28</xref>]. However, current evidence has implicated the circulating &#x003b2;<sub>2</sub>M in blood pressure regulation [<xref rid="B29-toxics-13-00081" ref-type="bibr">29</xref>], and &#x003b2;<sub>2</sub>M excretion above 300 &#x000b5;g/g creatinine is indicative of an increased risk of hypertension and severe kidney pathologies, such as rapid kidney functional deterioration and nephron loss for any reason [<xref rid="B30-toxics-13-00081" ref-type="bibr">30</xref>,<xref rid="B31-toxics-13-00081" ref-type="bibr">31</xref>,<xref rid="B32-toxics-13-00081" ref-type="bibr">32</xref>].</p><p>The present study has three major objectives. The first is to examine the dose&#x02013;response relationship between environmental Cd exposure levels and three adverse outcomes of such exposure, namely CKD, hypertension, and defective tubular function. Excretion of Cd (E<sub>Cd</sub>) and &#x003b2;<sub>2</sub>M (E<sub>&#x003b2;2M</sub>) were used as indicators of the long-term exposure or body burden of Cd and tubular dysfunction, respectively [<xref rid="B25-toxics-13-00081" ref-type="bibr">25</xref>]. The second objective is to explore a connection between E<sub>alb</sub> and the rising levels of systolic and diastolic blood pressure (SBP and DBP) in Cd-exposed people. The third objective is to address the female preponderance effects of environmental Cd exposure on blood pressure. These study objectives are formulated based on the current state of knowledge on the epidemiology of Cd toxicity and the significance of albuminuria as an independent risk factor for hypertension [<xref rid="B33-toxics-13-00081" ref-type="bibr">33</xref>], a strong independent risk factor for worse outcomes of cardiovascular disease, incident CKD, and its progression to kidney failure, especially among those with type 2 diabetes [<xref rid="B34-toxics-13-00081" ref-type="bibr">34</xref>,<xref rid="B35-toxics-13-00081" ref-type="bibr">35</xref>,<xref rid="B36-toxics-13-00081" ref-type="bibr">36</xref>,<xref rid="B37-toxics-13-00081" ref-type="bibr">37</xref>].</p></sec><sec id="sec2-toxics-13-00081"><title>2. Materials and Methods</title><sec id="sec2dot1-toxics-13-00081"><title>2.1. Participant Selection</title><p>We assembled archived data from large Thai population-based cohorts of residents in the Mae Sot District, Tak Province, where environmental Cd contamination was endemic (<italic toggle="yes">n</italic> = 310), and two low-exposure areas in Bangkok (<italic toggle="yes">n</italic> = 192) and Nakhon-Si-Thammarat Province (<italic toggle="yes">n</italic> = 139).</p><p>The parent cohorts were conducted in compliance with the principles outlined in the Declaration of Helsinki [<xref rid="B38-toxics-13-00081" ref-type="bibr">38</xref>,<xref rid="B39-toxics-13-00081" ref-type="bibr">39</xref>]. The respective study protocols for the Mae Sot plus Bangkok groups and the Nakhon Si Thammarat group were approved by the Institutional Ethical Committees of Chulalongkorn University, Chiang Mai University, and the Mae Sot Hospital (Approval No. 142/2544, 5 October 2001) [<xref rid="B38-toxics-13-00081" ref-type="bibr">38</xref>], as well as the Human Research Ethics Committee of Walailak University (Approval number WUEC-20-132-01, 28 May 2020) [<xref rid="B39-toxics-13-00081" ref-type="bibr">39</xref>]. All participants gave informed consent prior to participation.</p><p>For all groups, the exclusion criteria were pregnancy, breast-feeding, a history of metal work, and a hospital record or physician&#x02019;s diagnosis of an advanced chronic disease.</p><p>For the low-exposure groups, those aged 16 years or older were selected. The health status was ascertained by physician&#x02019;s examination reports and routine blood and urinary chemistry profiles. For the Mae Sot group, those who had resided at their current addresses for 30 years or longer were selected. The sociodemographic data, educational attainment, occupation, health status, family history of diabetes, and smoking status were obtained by structured interview questionnaires.</p><p>The diagnosis of hypertension was based on the assessment made by the presiding physician and the recorded use of anti-hypertensive medication. Most of the participants with hypertension (94.9%) were being treated, while 5.1% were identified during a visit.</p></sec><sec id="sec2dot2-toxics-13-00081"><title>2.2. Assessment of Cadmium Exposure Levels and Its Effects</title><p>Samples of urine, whole blood, and plasma were collected from all participants after an overnight fast and were stored at &#x02212;80 &#x000b0;C for later analysis. Plasma samples were assayed for the concentration of creatinine, while urine samples were assayed for the concentrations of creatinine, Cd, &#x003b2;<sub>2</sub>M, and alb, detailed previously [<xref rid="B38-toxics-13-00081" ref-type="bibr">38</xref>,<xref rid="B39-toxics-13-00081" ref-type="bibr">39</xref>].</p><p>The samples of soils and food crops from Nakhon Si Thammarat had arsenic, chromium, lead, and Cd within permissible ranges [<xref rid="B40-toxics-13-00081" ref-type="bibr">40</xref>]. The risk of having diabetes type 2 among Nakhon Si Thammarat residents was not associated with the water arsenic concentration [<xref rid="B41-toxics-13-00081" ref-type="bibr">41</xref>]. In comparison, the paddy soil samples from the Mae Sot district contained a Cd concentration exceeding the limit of 0.15 mg/kg, and household-storage rice samples contained four times the amount of the permissible Cd level of 0.1 mg/kg [<xref rid="B42-toxics-13-00081" ref-type="bibr">42</xref>]. The urinary Cd excretion levels were correlated with the prevalence of hypertension and diabetes type 2 found among residents of the Mae Sot District (<italic toggle="yes">n</italic> = 5273) [<xref rid="B43-toxics-13-00081" ref-type="bibr">43</xref>].</p><p>The eGFR was computed with equations of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) [<xref rid="B44-toxics-13-00081" ref-type="bibr">44</xref>,<xref rid="B45-toxics-13-00081" ref-type="bibr">45</xref>,<xref rid="B46-toxics-13-00081" ref-type="bibr">46</xref>]. CKD stages 1, 2, 3, 4, and 5 corresponded to eGFRs of 90&#x02013;119, 60&#x02013;89, 30&#x02013;59, 15&#x02013;29, and &#x0003c;15 mL/min/1.73 m<sup>2</sup>, respectively [<xref rid="B44-toxics-13-00081" ref-type="bibr">44</xref>,<xref rid="B45-toxics-13-00081" ref-type="bibr">45</xref>].</p></sec><sec id="sec2dot3-toxics-13-00081"><title>2.3. Normalization of Cadmium, &#x003b2;<sub>2</sub>M, and Albumin Excretion Rates</title><p>The excretion of x (E<sub>x</sub>) was normalized to the creatinine clearance (C<sub>cr</sub>) as E<sub>x</sub>/C<sub>cr</sub> = [x]<sub>u</sub>[cr]<sub>p</sub>/[cr]<sub>u</sub>, where x = Cd, &#x003b2;<sub>2</sub>M, or alb, [x]<sub>u</sub> = urine concentration of x (mass/volume), [cr]<sub>p</sub> = plasma creatinine concentration (mg/dL), and [cr]<sub>u</sub> = urine creatinine concentration (mg/dL). E<sub>x</sub>/C<sub>cr</sub>&#x02009;was expressed as an amount of x excreted per volume of the glomerular filtrate [<xref rid="B47-toxics-13-00081" ref-type="bibr">47</xref>]. This C<sub>cr</sub> normalization corrects for urine dilution and the number of functioning nephrons simultaneously, and it is not influenced by muscle mass.</p><p>The excretion of x (E<sub>x</sub>) was normalized to E<sub>cr</sub> as [x]<sub>u</sub>/[cr]<sub>u</sub>, where x = Cd, &#x003b2;<sub>2</sub>M, or alb, [x]<sub>u</sub> = urine concentration of x (mass/volume), and [cr]<sub>u</sub> = urine creatinine concentration (mg/dL). E<sub>x</sub>/E<sub>cr</sub> was expressed as an amount of x excreted per g of creatinine. This E<sub>cr</sub> normalization corrects for urine dilution only. This method of normalization of the excretion rate is affected by interindividual differences in muscle mass, which produces non-differential errors, and a clear dose&#x02013;response relationship of E<sub>Cd</sub> and E<sub>alb</sub> cannot be established [<xref rid="B48-toxics-13-00081" ref-type="bibr">48</xref>,<xref rid="B49-toxics-13-00081" ref-type="bibr">49</xref>].</p></sec><sec id="sec2dot4-toxics-13-00081"><title>2.4. Mediation Analysis for Cause&#x02013;Effect Inference</title><p>A simple mediation model with one mediator (M) and the Sobel test for the statistical significance of an indirect effect of the independent variable X were as described by MacKinnon et al. (1995) and Preacher and Hayes (2004) [<xref rid="B50-toxics-13-00081" ref-type="bibr">50</xref>,<xref rid="B51-toxics-13-00081" ref-type="bibr">51</xref>,<xref rid="B52-toxics-13-00081" ref-type="bibr">52</xref>].</p><p>A mediation model with M as a mediator of the effect of the independent variable X on the dependent variable Y and the standardized &#x003b2; coefficients describing the relationships of X, M, and Y are depicted below (<xref rid="toxics-13-00081-sch001" ref-type="fig">Scheme 1</xref>).</p></sec><sec id="sec2dot5-toxics-13-00081"><title>2.5. Statistical Analysis</title><p>The data were analyzed using IBM SPSS Statistics 21 (IBM Inc., New York, NY, USA). To assess the mean differences across E<sub>&#x003b2;2M</sub> groups, the Kruskal&#x02013;Wallis test was used. The Pearson chi-square test was used to assess the differences in percentages and prevalences of smoking, hypertension, low eGFR, diabetes, and albuminuria. The one-sample Kolmogorov&#x02013;Smirnov test was used to ascertain the conformity to a normal distribution of continuous variables. Logarithmic transformation was applied to E<sub>Cd</sub>, E<sub>&#x003b2;2M</sub>, and E<sub>alb</sub>, which showed a right-skewed distribution. For eGFR, no data transformation was required, because the distribution of eGFR values was left-skewed. Multiple linear regression was conducted to define the predictors of E<sub>alb</sub>/C<sub>cr</sub>.</p><p>Logistic regression was conducted to evaluate the effects of Cd exposure and other independent variables on the prevalence odds ratio (POR) for CKD, hypertension, tubular dysfunction, and albuminuria. All reported POR values were adjusted for potential confounders.</p><p>Univariate analysis was used to obtain the covariate adjusted mean E<sub>alb</sub>/C<sub>cr</sub> and eta square (&#x003b7;<sup>2</sup>), using the Bonferroni correction for comparing three eGFR groups. For all tests, <italic toggle="yes">p</italic>-values &#x02264; 0.05 were considered to indicate statistical significance.</p></sec></sec><sec sec-type="results" id="sec3-toxics-13-00081"><title>3. Results</title><sec sec-type="subjects" id="sec3dot1-toxics-13-00081"><title>3.1. Cohort Participants</title><p>As the data in <xref rid="toxics-13-00081-t001" ref-type="table">Table 1</xref> indicate, the overall mean age of the cohort participants was 47.5 years, and the overall arithmetic (geometric) mean for the Cd excretion rate was 0.024 (0.009) &#x000b5;g/L filtrate, corresponding to 2.98 (1.11) &#x000b5;g/g creatinine. The % of smokers and diabetics were 29 and 10.8, respectively. Hypertension was the most prevalent (39.8%), followed by albuminuria (16.5%) and a low eGFR (4.8%).</p><p>To explore the potential effects of tubular dysfunction, participants were grouped by E<sub>&#x003b2;2M</sub>/C<sub>cr</sub> values, and 422, 69, 61, and 61 participants were found to have E<sub>&#x003b2;2M</sub>/C<sub>cr</sub> values of 1.0&#x02013;2.9, 3.0&#x02013;9.9, and &#x02265;10 &#x000b5;g/L filtrate, respectively. The % hypertension, albuminuria, and low eGFR rose across E<sub>&#x003b2;2M</sub>/C<sub>cr</sub> groups. In the highest E<sub>&#x003b2;2M</sub>/C<sub>cr</sub> group, % hypertension, albuminuria, and a low eGFR were 62.3, 38.3, and 37.7, respectively. The corresponding % figures in the lowest E<sub>&#x003b2;2M</sub>/C<sub>cr</sub> group were 34.4, 9.4, and 0.7. The mean SBP and mean DBP increased across E<sub>&#x003b2;2M</sub>/C<sub>cr</sub> groups.</p></sec><sec id="sec3dot2-toxics-13-00081"><title>3.2. Effects of Cadmium on the Risks of Having CKD, Hypertension, and Tubular Malfunction</title><p>In three logistic regression analyses (<xref rid="toxics-13-00081-t002" ref-type="table">Table 2</xref>), the prevalence odds ratio (POR) values for CKD, hypertension, and tubular dysfunction were not affected by gender or smoking, but the age, BMI, and diabetes did.</p><p>Age increased the risk of all three outcomes, while a rise in the BMI only increased the risk of hypertension. The risks of having CKD and hypertension rose 3.5-fold (<italic toggle="yes">p</italic> &#x0003c; 0.001) and 1.2-fold (<italic toggle="yes">p</italic> &#x0003c; 0.001), respectively, as the body burden of Cd increased two-fold. Doubling the Cd burden had little effect on the risk of having tubular dysfunction, defined as the E<sub>&#x003b2;2M</sub>/C<sub>cr</sub> rates &#x02265; 3.0 &#x000b5;g/L filtrate [POR = 1.037 (95% CI: 0.917, 1.173), <italic toggle="yes">p</italic> = 0.567].</p><p>The tubular dysfunction was 17.7-time more prevalent among those with CKD. In comparison, all three outcomes were more prevalent among diabetics, compared with non-diabetics with the same overall Cd body burden.</p></sec><sec id="sec3dot3-toxics-13-00081"><title>3.3. Effects of Hypertension on the Prevalence of Albuminuria</title><p>In an inclusive logistic regression model (<xref rid="toxics-13-00081-t003" ref-type="table">Table 3</xref>), the prevalence of albuminuria was minimally affected by the age, Cd body burden, being obese, gender, and smoking, while albuminuria was 3.3 times more prevalent in participants with CKD (<italic toggle="yes">p</italic> = 0.014).</p><p>Subgroup analysis revealed that hypertension was the key determinant of albuminuria in people with CKD, diabetes, and tubular dysfunction. The prevalence of albuminuria was found to be increased only in those with CKD and hypertension (POR = 4.3, <italic toggle="yes">p</italic> = 0.040). Similarly, respective prevalences of albuminuria were increased 5.4-fold, 2.9-fold, and 4.2-fold in those with diabetes plus hypertension, severe tubular dysfunction plus hypertension, and extremely severe tubular dysfunction plus hypertension.</p></sec><sec id="sec3dot4-toxics-13-00081"><title>3.4. Dose&#x02013;Response Relationship and Quantitative Effect Size</title><p>As scatterplots indicate (<xref rid="toxics-13-00081-f001" ref-type="fig">Figure 1</xref>), a linear dose&#x02013;response relationship of E<sub>alb</sub>/C<sub>cr</sub> and E<sub>Cd</sub>/C<sub>cr</sub> was found only in the high-Cd burden group, defined as E<sub>Cd</sub>/C<sub>cr</sub> &#x02265; 0.01 &#x000b5;g/L filtrate, while a linear dose&#x02013;response relationship of E<sub>alb</sub>/C<sub>cr</sub> and blood pressure measures (SBP and DBP) existed in both the low- and high-Cd burden groups. E<sub>alb</sub>/C<sub>cr</sub> was more closely associated with SBP than DBP in both Cd burden groups.</p><p>The results of the multiple linear regression analysis of E<sub>alb</sub>/C<sub>cr</sub> (<xref rid="toxics-13-00081-t004" ref-type="table">Table 4</xref>) indicate that age, BMI, eGFR, Cd burden, diabetes, blood pressure, gender, and smoking contributed to 14.7% and 11.3% of the total E<sub>alb</sub>/C<sub>cr</sub> variation in the inclusive models 1 and 2, respectively.</p><p>In the SBP model including all subjects, the E<sub>alb</sub>/C<sub>cr</sub> varied inversely with the eGFR (&#x003b2; = &#x02212;0.180), while it varied directly with SBP (&#x003b2; = 0.263) and diabetes (&#x003b2; = 0.179). In the DBP model, the E<sub>alb</sub>/C<sub>cr</sub> was inversely associated with the eGFR (&#x003b2; = &#x02212;0.195), while it varied directly with DBP (&#x003b2; = 0.150) and diabetes (&#x003b2; = 0.220). In the DBP model only, the E<sub>alb</sub>/C<sub>cr</sub> showed a positive association with the E<sub>Cd</sub>/C<sub>cr</sub> (&#x003b2; = 0.122).</p><p>In the subgroup analysis, the E<sub>alb</sub>/C<sub>cr</sub> was inversely associated with the eGFR only in women, &#x003b2; = &#x02212;0.188 for the SBP model and &#x003b2; = &#x02212;0.201 for the DBP model. An association of E<sub>alb</sub>/C<sub>cr</sub> with DBP was also found in women only (&#x003b2; = 0.149). The E<sub>alb</sub>/C<sub>cr</sub> was associated with SBP and diabetes in both women and men in the SBP model. Similarly, the E<sub>alb</sub>/C<sub>cr</sub> was associated with diabetes in both women and men in the DBP model.</p><p>The influences of the Cd exposure levels and eGFR levels on albumin excretion among cohort participants are depicted in <xref rid="toxics-13-00081-f002" ref-type="fig">Figure 2</xref>, where the E<sub>alb</sub>/C<sub>cr</sub> increased linearly with the SBP in all three eGFR subgroups (<xref rid="toxics-13-00081-f002" ref-type="fig">Figure 2</xref>a), but the increase in the E<sub>alb</sub>/C<sub>cr</sub> with DBP was observed only in participants with CKD (<xref rid="toxics-13-00081-f002" ref-type="fig">Figure 2</xref>b).</p><p>In the univariate analysis for SBP effects with adjustment for covariates (<xref rid="toxics-13-00081-f002" ref-type="fig">Figure 2</xref>c), SBP contributed to 3.3% of the variation in E<sub>alb</sub>/C<sub>cr</sub> in those with SBP higher than the median SBP value of 130 mmHg. The mean values for E<sub>alb</sub>/C<sub>cr</sub> in participants with high SBP and CKD were 17.2% and 21.2% higher, compared to those with eGFR 61&#x02013;90 and &#x02265;90 mL/min/1.73 m<sup>2</sup>, respectively (<xref rid="toxics-13-00081-f002" ref-type="fig">Figure 2</xref>c).</p><p>In the univariate analysis for DBP effects with adjustment for covariates (<xref rid="toxics-13-00081-f002" ref-type="fig">Figure 2</xref>d), DBP contributed to 3.3% of the variation in E<sub>alb</sub>/C<sub>cr</sub> in those with a DBP higher than the DBP median value of 80 mmHg. The mean values for E<sub>alb</sub>/C<sub>cr</sub> in participants with high DBP and CKD were 19.0% and 22.5% higher, compared to those with eGFR 61&#x02013;90 and &#x02265;90 mL/min/1.73 m<sup>2</sup>, respectively (<xref rid="toxics-13-00081-f002" ref-type="fig">Figure 2</xref>d). Thus, the albumin excretion rate was increased in participants with CKD who also had a SBP and DBP higher than 130 and 80 mmHg, respectively.</p><p>A simple mediation analysis was conducted to assess the potential causal relationships of Cd exposure, eGFR and blood pressure levels (<xref rid="toxics-13-00081-f003" ref-type="fig">Figure 3</xref>).</p><p>A simple mediation analysis model of eGFR as the mediator suggested that Cd had direct and indirect effects on SBP and DBP (<xref rid="toxics-13-00081-f003" ref-type="fig">Figure 3</xref>a,b). However, the Sobel test results indicated that only the indirect effect of Cd on SBP reached a statistically significant level (<xref rid="toxics-13-00081-f003" ref-type="fig">Figure 3</xref>c,d). Thus, an increase in the SBP was in part due to reductions in the eGFR, and the proportion of Cd-induced SBP increment mediated by the eGFR decline was 80.6%. The rising DBP among participants was minimally related to Cd-induced eGFR reductions.</p><p>An additional simple mediation model with SBP or DBP as the mediator was conducted (<xref rid="toxics-13-00081-f004" ref-type="fig">Figure 4</xref>).</p><p>A direct effect of Cd on E<sub>alb</sub>/C<sub>cr</sub> was not evident in the SBP model (&#x003b2; = 0.041, <italic toggle="yes">p</italic> = 0.381) or the DBP model (&#x003b2; = &#x02212;0.015, <italic toggle="yes">p</italic> = 0.745) (<xref rid="toxics-13-00081-f004" ref-type="fig">Figure 4</xref>a,b). However, Cd had a significant indirect effect on the E<sub>alb</sub>/C<sub>cr</sub> increment, mediated fully through rising SBP and DBP levels (<xref rid="toxics-13-00081-f004" ref-type="fig">Figure 4</xref>c,d). Thus, SBP and DBP were the full mediators of an elevation of the albumin excretion rate induced by Cd.</p></sec></sec><sec sec-type="discussion" id="sec4-toxics-13-00081"><title>4. Discussion</title><p>The percentage (%) of hypertension among 641 cohort participants was the highest (39.8), followed by albuminuria (16.5), and low eGFR (4.8), while the percentages of smoking and diabetes were 29 and 10.8, respectively (<xref rid="toxics-13-00081-t001" ref-type="table">Table 1</xref>). The % of hypertension and diabetes were in ranges with those reported for the representative U.S. population of 39 and 10.3&#x02013;13, respectively [<xref rid="B53-toxics-13-00081" ref-type="bibr">53</xref>,<xref rid="B54-toxics-13-00081" ref-type="bibr">54</xref>]. The CKD (a low eGFR criterion) prevalence in this Thai cohort of 4.8% was lower than the 6.8% CKD prevalence figure in the Taiwanese population [<xref rid="B55-toxics-13-00081" ref-type="bibr">55</xref>], but it was nearly half the prevalence of 9.3% found in a large U.S. population database, where 5175 CKD cases were identified from a total of 55,677 U.S. citizens, aged 20&#x02212;85 years [<xref rid="B15-toxics-13-00081" ref-type="bibr">15</xref>].</p><sec id="sec4dot1-toxics-13-00081"><title>4.1. Low eGFR, Hypertension, and Albuminuria: Are They Causally Connected?</title><p>Albuminuria was 3.3-times more prevalent among participants with CKD, and the risks of having CKD and hypertension rose, respectively, 3.5-fold and 1.2-fold, when there was a two-fold increase in the body burden of Cd (<xref rid="toxics-13-00081-t001" ref-type="table">Table 1</xref> and <xref rid="toxics-13-00081-t002" ref-type="table">Table 2</xref>). Hypertension was found to be the key determinant of albuminuria in participants with CKD; the risk of having albuminuria only increased in those with CKD plus hypertension (POR = 4.3) (<xref rid="toxics-13-00081-t003" ref-type="table">Table 3</xref>).</p><p>We employed two simple mediation models to assess potential causal relationships of Cd exposure, eGFR, and blood pressure levels. In the model in which eGFR was the mediator (<xref rid="toxics-13-00081-f003" ref-type="fig">Figure 3</xref>), the increase in the SBP levels among the cohort participants was in part due to the reductions in eGFR. The proportion of the Cd-induced SBP increment mediated by the eGFR decline was 80.6%. The rising DBP among participants was minimally related to the Cd-induced eGFR reductions.</p><p>In the model in which SBP or DBP was the mediator (<xref rid="toxics-13-00081-f004" ref-type="fig">Figure 4</xref>), an elevation of the albumin excretion rate induced by Cd was through the rising SBP and DBP. Thus, albuminuria in Cd-exposed people appeared to be a consequence of a Cd-induced GFR fall, which causes the SBP and DBP to rise along with the excretion rate of albumin.</p><p>Herein, three outcomes of Cd exposure, namely a low eGFR, hypertension, and albuminuria, were investigated for dose&#x02013;response and potential cause&#x02013;effect inference. No previous studies have been undertaken to investigate the connection of these three outcomes. The cause-effect relationships of the Cd exposure levels, eGFR reductions, and blood pressure increment have been observed previously in a cohort of 447 Thai adults with a higher exposure level than participants in the present study [<xref rid="B56-toxics-13-00081" ref-type="bibr">56</xref>]. The results suggested that Cd may increase blood pressure by destroying nephrons, which then caused the blood pressure to rise. This explains a universally high prevalence of hypertension in CKD patients.</p><p>A significant increase in the albumin excretion rate was found in participants with SBP and DBP within normal ranges (<xref rid="toxics-13-00081-f002" ref-type="fig">Figure 2</xref>). The mean values for the albumin excretion rate (E<sub>alb</sub>/C<sub>cr</sub>) among cohort participants who had a low eGFR and an SBP higher than the median 130 mmHg were 17.2% and 21.2% higher, compared to those with an eGFR 61&#x02013;90 and &#x02265;90 mL/min/1.73 m<sup>2</sup>, respectively (<xref rid="toxics-13-00081-f002" ref-type="fig">Figure 2</xref>). These results were obtained after adjustment for potential confounders. In addition, the lowest eGFR group with a DBP higher than the median of &#x02265; 80 mmHg excreted albumin at 19.0% and 22.5% higher rates than those with an eGFR 61&#x02013;90 and &#x02265;90 mL/min/1.73 m<sup>2</sup>, respectively. Intriguingly, in the SPRINT Trial (<italic toggle="yes">n</italic> = 2436), participants who had a low eGFR and an SBP of 16 mmHg higher than a mean value were found to have a 16% higher albumin excretion rate [<xref rid="B57-toxics-13-00081" ref-type="bibr">57</xref>].</p><p>In the present study, the albumin excretion rate and albuminuria were analyzed as additional parameters including data from the Bangkok residents (a total 641 participants). The present study has first demonstrated a significant relationship between blood pressure and albumin excretion. This finding is of clinical significance because proteinuria (albuminuria) is a predictive of a continuing decline of the kidney function. Previously, we have analyzed albuminuria among Mae Sot residents with high-dose Cd exposure, resulting in overt tubular malfunction, where we found that Cd may impair the receptor mediated endocytosis for albumin [<xref rid="B9-toxics-13-00081" ref-type="bibr">9</xref>]. It was estimated that Cd reduced the fractional reabsorption of albumin by 20%, if a glomerular sieving coefficient for albumin (GSC<sub>alb</sub>) of 10<sup>&#x02212;4</sup> was assumed [<xref rid="B9-toxics-13-00081" ref-type="bibr">9</xref>].</p></sec><sec id="sec4dot2-toxics-13-00081"><title>4.2. Effects of Cadmium in Women and Men</title><p>By multiple regression analysis including all subjects, age, BMI, eGFR, Cd burden, diabetes, blood pressure, gender, and smoking contributed significantly to the variability of E<sub>alb</sub>/C<sub>cr</sub> among cohort participants (<xref rid="toxics-13-00081-t004" ref-type="table">Table 4</xref>). An inverse relationship between the E<sub>alb</sub>/C<sub>cr</sub> and eGFR was found only in women (&#x003b2; = &#x02212;0.188 for SBP model and &#x003b2; = &#x02212;0.201 for DBP model). An association of E<sub>alb</sub>/C<sub>cr</sub> with DBP was also found only in women (&#x003b2; = 0.149). The reasons for the female preponderance effect of Cd on blood pressure and albuminuria were not apparent from the present study. Further research is warranted.</p><p>Typically, hypertension is more prevalent in men, compared to age-matched premenopausal women [<xref rid="B58-toxics-13-00081" ref-type="bibr">58</xref>,<xref rid="B59-toxics-13-00081" ref-type="bibr">59</xref>,<xref rid="B60-toxics-13-00081" ref-type="bibr">60</xref>], and the differences of the Cd effects in men and women were related to sex hormones. An increase in the urinary Cd excretion levels from &#x0003c;2 to &#x02265;3&#x02009;&#x003bc;g/g creatinine was associated with a 28% increase in serum testosterone in postmenopausal Japanese women [<xref rid="B61-toxics-13-00081" ref-type="bibr">61</xref>]. An inverse association between urinary Cd and serum estradiol levels was noted in postmenopausal Japanese and Swedish women [<xref rid="B62-toxics-13-00081" ref-type="bibr">62</xref>,<xref rid="B63-toxics-13-00081" ref-type="bibr">63</xref>]. In the Swiss Kidney Project on Genes in Hypertension [<xref rid="B64-toxics-13-00081" ref-type="bibr">64</xref>], the urinary Cd correlated with testosterone excretion in men, while there was a trend for an association in women.</p></sec><sec id="sec4dot3-toxics-13-00081"><title>4.3. Implications for the Toxicological Risk Assessment of Dietary Cadmium Exposure</title><p>Hypertension, albuminuria, and CKD have been found repeatedly in people with a low body burden of Cd. The risk of having hypertension doubled at a Cd excretion rate of 0.98 &#x000b5;g/g creatinine and a blood Cd level of 0.61 &#x000b5;g/L [<xref rid="B56-toxics-13-00081" ref-type="bibr">56</xref>]. Similarly, an analysis of U.S. population data reported that the risk of having CKD increased 2.1-fold, 3.2-fold, and 5.5-fold in people who had blood Cd concentrations of 0.21&#x02013;0.35, 0.36&#x02013;0.60, and &#x0003e;0.60 &#x000b5;g/L, respectively [<xref rid="B15-toxics-13-00081" ref-type="bibr">15</xref>].</p><p>Furthermore, given the same Cd body burden, the risk of having albuminuria was the highest (POR = 5.4) in diabetics with hypertension, compared to participants with severe tubular dysfunction plus hypertension (POR = 2.9) and participants with extremely severe tubular dysfunction plus hypertension (POR = 4.2) (<xref rid="toxics-13-00081-t003" ref-type="table">Table 3</xref>). Thus, people with diabetes were highly susceptible to the nephrotoxicity of Cd. Consistent with our observation, a Dutch cross-sectional study, including 231 patients with type 2 diabetes, reported that low Cd exposure increased the risk of diabetic kidney disease [<xref rid="B65-toxics-13-00081" ref-type="bibr">65</xref>,<xref rid="B66-toxics-13-00081" ref-type="bibr">66</xref>]. In a six-year median follow-up of these patients, a progressive reduction of eGFR to kidney failure was linked to Cd exposure [<xref rid="B61-toxics-13-00081" ref-type="bibr">61</xref>].</p><p>In the present study, albuminuria was 3.4-times more prevalent than a low eGFR. This underscores the utility of an elevated albumin excretion for early CKD detection purposes, given that CKD in its early stage is largely asymptomatic. This makes its early detection difficult and the initiation of early treatment, which can significantly prevent CKD progression, limited. An ACR as low as 7 mg/g creatinine was a predictor of incident CKD within 10 years [<xref rid="B36-toxics-13-00081" ref-type="bibr">36</xref>]. An ACR &#x02265;10 mg/g creatinine may increase mortality from all causes and CVD [<xref rid="B37-toxics-13-00081" ref-type="bibr">37</xref>].</p><p>The strength of this study includes a high number of participants with diagnosed hypertension, as it meant that a reliable conclusion could be drawn from a cohort of a modest sample size (<italic toggle="yes">n</italic> &#x0003c; 1000). An additional strength includes the consideration given to a sample representative of the general population and the potential effects of smoking and diabetes in realistic population situations. A cross-sectional study design involving a one-time Cd exposure assessment was a limitation. Because of the difference in hormonal status, including menopausal and post-menopausal women in this study was another limitation.</p></sec></sec><sec sec-type="conclusions" id="sec5-toxics-13-00081"><title>5. Conclusions</title><p>Through the mediation analysis, this study shows, for the first time, that an elevation in the albumin excretion rate is caused by an increase in blood pressure, notably SBP, which arises from Cd-induced GFR reductions. A declining eGFR and rising SBP can serve as sensitive endpoints suitable for the health risk assessment of exposure to dietary Cd and the derivation of the health-protective exposure limit.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by resources from the Centre for Kidney Disease Research, Translational Research Institute, the Department of Kidney and Transplant Services, Princess Alexandra Hospital, the Department of Toxicology, Faculty of Pharmacy, University of Belgrade, Serbia.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, S.S., D.A.V. and A.B.&#x00110;.; methodology, S.Y., T.K. and P.P.; formal analysis, S.S. and A.B.&#x00110;.; investigation, S.S., S.Y., T.K. and P.P.; resources, D.A.V., S.Y. and A.B.&#x00110;.; data curation, S.S. and S.Y.; writing&#x02014;original draft preparation, S.S.; writing&#x02014;review and editing, S.S., D.A.V. and A.B.&#x00110;.; project administration, S.S. and S.Y. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>The parent cohorts were conducted in compliance with the principles outlined in the Declaration of Helsinki. The Institutional Ethical Committees of Chulalongkorn University, Chiang Mai University, and the Mae Sot Hospital approved the study protocol for the Mae Sot and Bangkok groups (Approval No. 142/2544, 5 October 2001). The Human Research Ethics Committee of Walailak University approved the study protocol for the Nakhon Si Thammarat group (Approval number WUEC-20-132-01, 28 May 2020).</p></notes><notes><title>Informed Consent Statement</title><p>Written informed consent was obtained from the study subjects.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>All data are contained within this article.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-toxics-13-00081"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Murton</surname><given-names>M.</given-names></name>
<name><surname>Goff-Leggett</surname><given-names>D.</given-names></name>
<name><surname>Bobrowska</surname><given-names>A.</given-names></name>
<name><surname>Garcia Sanchez</surname><given-names>J.J.</given-names></name>
<name><surname>James</surname><given-names>G.</given-names></name>
<name><surname>Wittbrodt</surname><given-names>E.</given-names></name>
<name><surname>Nolan</surname><given-names>S.</given-names></name>
<name><surname>S&#x000f6;rstadius</surname><given-names>E.</given-names></name>
<name><surname>Pecoits-Filho</surname><given-names>R.</given-names></name>
<name><surname>Tuttle</surname><given-names>K.</given-names></name>
</person-group><article-title>Burden of Chronic Kidney Disease by KDIGO Categories of Glomerular Filtration Rate and Albuminuria: A Systematic Review</article-title><source>Adv. Ther.</source><year>2021</year><volume>38</volume><fpage>180</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1007/s12325-020-01568-8</pub-id><pub-id pub-id-type="pmid">33231861</pub-id>
</element-citation></ref><ref id="B2-toxics-13-00081"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Evans</surname><given-names>M.</given-names></name>
<name><surname>Lewis</surname><given-names>R.D.</given-names></name>
<name><surname>Morgan</surname><given-names>A.R.</given-names></name>
<name><surname>Whyte</surname><given-names>M.B.</given-names></name>
<name><surname>Hanif</surname><given-names>W.</given-names></name>
<name><surname>Bain</surname><given-names>S.C.</given-names></name>
<name><surname>Davies</surname><given-names>S.</given-names></name>
<name><surname>Dashora</surname><given-names>U.</given-names></name>
<name><surname>Yousef</surname><given-names>Z.</given-names></name>
<name><surname>Patel</surname><given-names>D.C.</given-names></name>
<etal/>
</person-group><article-title>A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future Perspectives</article-title><source>Adv. Ther.</source><year>2022</year><volume>39</volume><fpage>33</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1007/s12325-021-01927-z</pub-id><pub-id pub-id-type="pmid">34739697</pub-id>
</element-citation></ref><ref id="B3-toxics-13-00081"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Farrell</surname><given-names>D.R.</given-names></name>
<name><surname>Vassalotti</surname><given-names>J.A.</given-names></name>
</person-group><article-title>Screening, identifying, and treating chronic kidney disease: Why, who, when, how, and what?</article-title><source>BMC Nephrol.</source><year>2024</year><volume>25</volume><elocation-id>34</elocation-id><pub-id pub-id-type="doi">10.1186/s12882-024-03466-5</pub-id><pub-id pub-id-type="pmid">38273240</pub-id>
</element-citation></ref><ref id="B4-toxics-13-00081"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Foreman</surname><given-names>K.J.</given-names></name>
<name><surname>Marquez</surname><given-names>N.</given-names></name>
<name><surname>Dolgert</surname><given-names>A.</given-names></name>
<name><surname>Fukutaki</surname><given-names>K.</given-names></name>
<name><surname>Fullman</surname><given-names>N.</given-names></name>
<name><surname>McGaughey</surname><given-names>M.</given-names></name>
<name><surname>Pletcher</surname><given-names>M.A.</given-names></name>
<name><surname>Smith</surname><given-names>A.E.</given-names></name>
<name><surname>Tang</surname><given-names>K.</given-names></name>
<name><surname>Yuan</surname><given-names>C.W.</given-names></name>
<etal/>
</person-group><article-title>Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: Reference and alternative scenarios for 2016-40 for 195 countries and territories</article-title><source>Lancet</source><year>2018</year><volume>392</volume><fpage>2052</fpage><lpage>2090</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(18)31694-5</pub-id><pub-id pub-id-type="pmid">30340847</pub-id>
</element-citation></ref><ref id="B5-toxics-13-00081"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<collab>GBD 2021 Forecasting Collaborators</collab>
</person-group><article-title>Burden of disease scenarios for 204 countries and territories, 2022&#x02013;2050: A forecasting analysis for the Global Burden of Disease Study 2021</article-title><source>Lancet</source><year>2024</year><volume>403</volume><fpage>2204</fpage><lpage>2256</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(24)00685-8</pub-id><pub-id pub-id-type="pmid">38762325</pub-id>
</element-citation></ref><ref id="B6-toxics-13-00081"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wei</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>X.</given-names></name>
<name><surname>Sun</surname><given-names>Q.</given-names></name>
<name><surname>Shi</surname><given-names>W.</given-names></name>
<name><surname>Zhang</surname><given-names>W.</given-names></name>
<name><surname>Gao</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>Y.</given-names></name>
<name><surname>Hao</surname><given-names>R.</given-names></name>
<name><surname>Dong</surname><given-names>X.</given-names></name>
<name><surname>Chen</surname><given-names>C.</given-names></name>
<etal/>
</person-group><article-title>Associations of environmental cadmium exposure with kidney damage: Exploring mediating DNA methylation sites in Chinese adults</article-title><source>Environ. Res.</source><year>2024</year><volume>251</volume><issue-part>Pt 1</issue-part><fpage>118667</fpage><pub-id pub-id-type="doi">10.1016/j.envres.2024.118667</pub-id><pub-id pub-id-type="pmid">38462081</pub-id>
</element-citation></ref><ref id="B7-toxics-13-00081"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sakuma</surname><given-names>S.</given-names></name>
<name><surname>Nogawa</surname><given-names>K.</given-names></name>
<name><surname>Watanabe</surname><given-names>Y.</given-names></name>
<name><surname>Sakurai</surname><given-names>M.</given-names></name>
<name><surname>Nishijo</surname><given-names>M.</given-names></name>
<name><surname>Ishizaki</surname><given-names>M.</given-names></name>
<name><surname>Morikawa</surname><given-names>Y.</given-names></name>
<name><surname>Kido</surname><given-names>T.</given-names></name>
<name><surname>Nakagawa</surname><given-names>H.</given-names></name>
<name><surname>Suwazono</surname><given-names>Y.</given-names></name>
</person-group><article-title>Effect of renal tubular damage on non-cancer mortality in the general Japanese population living in cadmium non-polluted areas</article-title><source>J. Appl. Toxicol.</source><year>2023</year><volume>43</volume><fpage>1849</fpage><lpage>1858</lpage><pub-id pub-id-type="doi">10.1002/jat.4518</pub-id><pub-id pub-id-type="pmid">37460094</pub-id>
</element-citation></ref><ref id="B8-toxics-13-00081"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Smerecza&#x00144;ski</surname><given-names>N.M.</given-names></name>
<name><surname>Brz&#x000f3;ska</surname><given-names>M.M.</given-names></name>
</person-group><article-title>Current levels of environmental exposure to cadmium in industrialized countries as a risk factor for kidney damage in the general population: A comprehensive review of available data</article-title><source>Int. J. Mol. Sci.</source><year>2023</year><volume>24</volume><elocation-id>8413</elocation-id><pub-id pub-id-type="doi">10.3390/ijms24098413</pub-id><pub-id pub-id-type="pmid">37176121</pub-id>
</element-citation></ref><ref id="B9-toxics-13-00081"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Satarug</surname><given-names>S.</given-names></name>
<name><surname>Vesey</surname><given-names>D.A.</given-names></name>
<name><surname>Gobe</surname><given-names>G.C.</given-names></name>
<name><surname>Phelps</surname><given-names>K.R.</given-names></name>
</person-group><article-title>The pathogenesis of albuminuria in cadmium nephropathy</article-title><source>Curr. Res. Toxicol.</source><year>2023</year><volume>6</volume><fpage>100140</fpage><pub-id pub-id-type="doi">10.1016/j.crtox.2023.100140</pub-id><pub-id pub-id-type="pmid">38116328</pub-id>
</element-citation></ref><ref id="B10-toxics-13-00081"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Satarug</surname><given-names>S.</given-names></name>
<name><surname>Vesey</surname><given-names>D.A.</given-names></name>
<name><surname>Gobe</surname><given-names>G.C.</given-names></name>
<name><surname>Yimthiang</surname><given-names>S.</given-names></name>
<name><surname>Buha &#x00110;or&#x00111;evi&#x00107;</surname><given-names>A.</given-names></name>
</person-group><article-title>Health Risk in a Geographic Area of Thailand with Endemic Cadmium Contamination: Focus on Albuminuria</article-title><source>Toxics</source><year>2023</year><volume>11</volume><elocation-id>68</elocation-id><pub-id pub-id-type="doi">10.3390/toxics11010068</pub-id><pub-id pub-id-type="pmid">36668794</pub-id>
</element-citation></ref><ref id="B11-toxics-13-00081"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Grau-Perez</surname><given-names>M.</given-names></name>
<name><surname>Pichler</surname><given-names>G.</given-names></name>
<name><surname>Galan-Chilet</surname><given-names>I.</given-names></name>
<name><surname>Briongos-Figuero</surname><given-names>L.S.</given-names></name>
<name><surname>Rentero-Garrido</surname><given-names>P.</given-names></name>
<name><surname>Lopez-Izquierdo</surname><given-names>R.</given-names></name>
<name><surname>Navas-Acien</surname><given-names>A.</given-names></name>
<name><surname>Weaver</surname><given-names>V.</given-names></name>
<name><surname>Garc&#x000ed;a-Barrera</surname><given-names>T.</given-names></name>
<name><surname>Gomez-Ariza</surname><given-names>J.L.</given-names></name>
<etal/>
</person-group><article-title>Urine cadmium levels and albuminuria in a general population from Spain: A gene-environment interaction analysis</article-title><source>Environ. Int.</source><year>2017</year><volume>106</volume><fpage>27</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.envint.2017.05.008</pub-id><pub-id pub-id-type="pmid">28558300</pub-id>
</element-citation></ref><ref id="B12-toxics-13-00081"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tsai</surname><given-names>H.J.</given-names></name>
<name><surname>Hung</surname><given-names>C.H.</given-names></name>
<name><surname>Wang</surname><given-names>C.W.</given-names></name>
<name><surname>Tu</surname><given-names>H.P.</given-names></name>
<name><surname>Li</surname><given-names>C.H.</given-names></name>
<name><surname>Tsai</surname><given-names>C.C.</given-names></name>
<name><surname>Lin</surname><given-names>W.Y.</given-names></name>
<name><surname>Chen</surname><given-names>S.C.</given-names></name>
<name><surname>Kuo</surname><given-names>C.H.</given-names></name>
</person-group><article-title>Associations among Heavy Metals and Proteinuria and Chronic Kidney Disease</article-title><source>Diagnostics</source><year>2021</year><volume>11</volume><elocation-id>282</elocation-id><pub-id pub-id-type="doi">10.3390/diagnostics11020282</pub-id><pub-id pub-id-type="pmid">33670331</pub-id>
</element-citation></ref><ref id="B13-toxics-13-00081"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jalili</surname><given-names>C.</given-names></name>
<name><surname>Kazemi</surname><given-names>M.</given-names></name>
<name><surname>Cheng</surname><given-names>H.</given-names></name>
<name><surname>Mohammadi</surname><given-names>H.</given-names></name>
<name><surname>Babaei</surname><given-names>A.</given-names></name>
<name><surname>Taheri</surname><given-names>E.</given-names></name>
<name><surname>Moradi</surname><given-names>S.</given-names></name>
</person-group><article-title>Associations between exposure to heavy metals and the risk of chronic kidney disease: A systematic review and meta-analysis</article-title><source>Crit. Rev. Toxicol.</source><year>2021</year><volume>51</volume><fpage>165</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1080/10408444.2021.1891196</pub-id><pub-id pub-id-type="pmid">33960873</pub-id>
</element-citation></ref><ref id="B14-toxics-13-00081"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Doccioli</surname><given-names>C.</given-names></name>
<name><surname>Sera</surname><given-names>F.</given-names></name>
<name><surname>Francavilla</surname><given-names>A.</given-names></name>
<name><surname>Cupisti</surname><given-names>A.</given-names></name>
<name><surname>Biggeri</surname><given-names>A.</given-names></name>
</person-group><article-title>Association of cadmium environmental exposure with chronic kidney disease: A systematic review and meta-analysis</article-title><source>Sci. Total Environ.</source><year>2024</year><volume>906</volume><fpage>167165</fpage><pub-id pub-id-type="doi">10.1016/j.scitotenv.2023.167165</pub-id><pub-id pub-id-type="pmid">37758140</pub-id>
</element-citation></ref><ref id="B15-toxics-13-00081"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Akinleye</surname><given-names>A.</given-names></name>
<name><surname>Oremade</surname><given-names>O.</given-names></name>
<name><surname>Xu</surname><given-names>X.</given-names></name>
</person-group><article-title>Exposure to low levels of heavy metals and chronic kidney disease in the US population: A cross-sectional study</article-title><source>PLoS ONE</source><year>2024</year><volume>19</volume><elocation-id>e0288190</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0288190</pub-id><pub-id pub-id-type="pmid">38625896</pub-id>
</element-citation></ref><ref id="B16-toxics-13-00081"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Satarug</surname><given-names>S.</given-names></name>
<name><surname>Vesey</surname><given-names>D.A.</given-names></name>
<name><surname>Nishijo</surname><given-names>M.</given-names></name>
<name><surname>Ruangyuttikarn</surname><given-names>W.</given-names></name>
<name><surname>Gobe</surname><given-names>G.C.</given-names></name>
<name><surname>Phelps</surname><given-names>K.R.</given-names></name>
</person-group><article-title>The Effect of Cadmium on GFR Is Clarified by Normalization of Excretion Rates to Creatinine Clearance</article-title><source>Int. J. Mol. Sci.</source><year>2021</year><volume>22</volume><elocation-id>1762</elocation-id><pub-id pub-id-type="doi">10.3390/ijms22041762</pub-id><pub-id pub-id-type="pmid">33578883</pub-id>
</element-citation></ref><ref id="B17-toxics-13-00081"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Satarug</surname><given-names>S.</given-names></name>
<name><surname>&#x00110;or&#x00111;evi&#x00107;</surname><given-names>A.B.</given-names></name>
<name><surname>Yimthiang</surname><given-names>S.</given-names></name>
<name><surname>Vesey</surname><given-names>D.A.</given-names></name>
<name><surname>Gobe</surname><given-names>G.C.</given-names></name>
</person-group><article-title>The NOAEL Equivalent of Environmental Cadmium Exposure Associated with GFR Reduction and Chronic Kidney Disease</article-title><source>Toxics</source><year>2022</year><volume>10</volume><elocation-id>614</elocation-id><pub-id pub-id-type="doi">10.3390/toxics10100614</pub-id><pub-id pub-id-type="pmid">36287894</pub-id>
</element-citation></ref><ref id="B18-toxics-13-00081"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>X.</given-names></name>
<name><surname>Ma</surname><given-names>Z.</given-names></name>
<name><surname>Dang</surname><given-names>Y.</given-names></name>
<name><surname>Yang</surname><given-names>Y.</given-names></name>
<name><surname>Cao</surname><given-names>S.</given-names></name>
<name><surname>Ouyang</surname><given-names>C.</given-names></name>
<name><surname>Shi</surname><given-names>X.</given-names></name>
<name><surname>Pan</surname><given-names>J.</given-names></name>
<name><surname>Hu</surname><given-names>X.</given-names></name>
</person-group><article-title>Associations of urinary and blood cadmium concentrations with all-cause mortality in US adults with chronic kidney disease: A prospective cohort study</article-title><source>Environ. Sci. Pollut. Res. Int.</source><year>2023</year><volume>30</volume><fpage>61659</fpage><lpage>61671</lpage><pub-id pub-id-type="doi">10.1007/s11356-023-26451-1</pub-id><pub-id pub-id-type="pmid">36933131</pub-id>
</element-citation></ref><ref id="B19-toxics-13-00081"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Satarug</surname><given-names>S.</given-names></name>
<name><surname>Vesey</surname><given-names>D.A.</given-names></name>
<name><surname>Gobe</surname><given-names>G.C.</given-names></name>
<name><surname>Phelps</surname><given-names>K.R.</given-names></name>
</person-group><article-title>Estimation of health risks associated with dietary cadmium exposure</article-title><source>Arch. Toxicol.</source><year>2023</year><volume>97</volume><fpage>329</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1007/s00204-022-03432-w</pub-id><pub-id pub-id-type="pmid">36592197</pub-id>
</element-citation></ref><ref id="B20-toxics-13-00081"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fechner</surname><given-names>C.</given-names></name>
<name><surname>Hackethal</surname><given-names>C.</given-names></name>
<name><surname>H&#x000f6;pfner</surname><given-names>T.</given-names></name>
<name><surname>Dietrich</surname><given-names>J.</given-names></name>
<name><surname>Bloch</surname><given-names>D.</given-names></name>
<name><surname>Lindtner</surname><given-names>O.</given-names></name>
<name><surname>Sarvan</surname><given-names>I.</given-names></name>
</person-group><article-title>Results of the BfR MEAL Study: In Germany, mercury is mostly contained in fish and seafood while cadmium, lead, and nickel are present in a broad spectrum of foods</article-title><source>Food Chem. X</source><year>2022</year><volume>14</volume><fpage>100326</fpage><pub-id pub-id-type="doi">10.1016/j.fochx.2022.100326</pub-id><pub-id pub-id-type="pmid">35601214</pub-id>
</element-citation></ref><ref id="B21-toxics-13-00081"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Watanabe</surname><given-names>T.</given-names></name>
<name><surname>Kataoka</surname><given-names>Y.</given-names></name>
<name><surname>Hayashi</surname><given-names>K.</given-names></name>
<name><surname>Matsuda</surname><given-names>R.</given-names></name>
<name><surname>Uneyama</surname><given-names>C.</given-names></name>
</person-group><article-title>Dietary exposure of the Japanese general population to elements: Total diet study 2013&#x02013;2018</article-title><source>Food Saf.</source><year>2022</year><volume>10</volume><fpage>83</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.14252/foodsafetyfscj.D-22-00003</pub-id><pub-id pub-id-type="pmid">36237396</pub-id>
</element-citation></ref><ref id="B22-toxics-13-00081"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pokharel</surname><given-names>A.</given-names></name>
<name><surname>Wu</surname><given-names>F.</given-names></name>
</person-group><article-title>Dietary exposure to cadmium from six common foods in the United States</article-title><source>Food Chem. Toxicol.</source><year>2023</year><volume>178</volume><fpage>113873</fpage><pub-id pub-id-type="doi">10.1016/j.fct.2023.113873</pub-id><pub-id pub-id-type="pmid">37271274</pub-id>
</element-citation></ref><ref id="B23-toxics-13-00081"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Almerud</surname><given-names>P.</given-names></name>
<name><surname>Zamaratskaia</surname><given-names>G.</given-names></name>
<name><surname>Lindroos</surname><given-names>A.K.</given-names></name>
<name><surname>Bjermo</surname><given-names>H.</given-names></name>
<name><surname>Andersson</surname><given-names>E.M.</given-names></name>
<name><surname>Lundh</surname><given-names>T.</given-names></name>
<name><surname>Ankarberg</surname><given-names>E.H.</given-names></name>
<name><surname>Lignell</surname><given-names>S.</given-names></name>
</person-group><article-title>Cadmium, total mercury, and lead in blood and associations with diet, sociodemographic factors, and smoking in Swedish adolescents</article-title><source>Environ. Res.</source><year>2021</year><volume>197</volume><fpage>110991</fpage><pub-id pub-id-type="doi">10.1016/j.envres.2021.110991</pub-id><pub-id pub-id-type="pmid">33705767</pub-id>
</element-citation></ref><ref id="B24-toxics-13-00081"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pappas</surname><given-names>R.S.</given-names></name>
<name><surname>Fresquez</surname><given-names>M.R.</given-names></name>
<name><surname>Watson</surname><given-names>C.H.</given-names></name>
</person-group><article-title>Cigarette smoke cadmium breakthrough from traditional filters: Implications for exposure</article-title><source>J. Anal. Toxicol.</source><year>2015</year><volume>39</volume><fpage>45</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1093/jat/bku115</pub-id><pub-id pub-id-type="pmid">25313385</pub-id>
</element-citation></ref><ref id="B25-toxics-13-00081"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hill</surname><given-names>D.T.</given-names></name>
<name><surname>Jandev</surname><given-names>V.</given-names></name>
<name><surname>Petroni</surname><given-names>M.</given-names></name>
<name><surname>Atallah-Yunes</surname><given-names>N.</given-names></name>
<name><surname>Bendinskas</surname><given-names>K.</given-names></name>
<name><surname>Brann</surname><given-names>L.S.</given-names></name>
<name><surname>Heffernan</surname><given-names>K.</given-names></name>
<name><surname>Larsen</surname><given-names>D.A.</given-names></name>
<name><surname>MacKenzie</surname><given-names>J.A.</given-names></name>
<name><surname>Palmer</surname><given-names>C.D.</given-names></name>
<etal/>
</person-group><article-title>Airborne levels of cadmium are correlated with urinary cadmium concentrations among young children living in the New York state city of Syracuse, USA</article-title><source>Environ. Res.</source><year>2023</year><volume>223</volume><fpage>115450</fpage><pub-id pub-id-type="doi">10.1016/j.envres.2023.115450</pub-id><pub-id pub-id-type="pmid">36764435</pub-id>
</element-citation></ref><ref id="B26-toxics-13-00081"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Satarug</surname><given-names>S.</given-names></name>
<name><surname>Vesey</surname><given-names>D.A.</given-names></name>
<name><surname>Ruangyuttikarn</surname><given-names>W.</given-names></name>
<name><surname>Nishijo</surname><given-names>M.</given-names></name>
<name><surname>Gobe</surname><given-names>G.C.</given-names></name>
<name><surname>Phelps</surname><given-names>K.R.</given-names></name>
</person-group><article-title>The Source and Pathophysiologic Significance of Excreted Cadmium</article-title><source>Toxics</source><year>2019</year><volume>7</volume><elocation-id>55</elocation-id><pub-id pub-id-type="doi">10.3390/toxics7040055</pub-id><pub-id pub-id-type="pmid">31635341</pub-id>
</element-citation></ref><ref id="B27-toxics-13-00081"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hayashi</surname><given-names>T.</given-names></name>
<name><surname>Nogawa</surname><given-names>K.</given-names></name>
<name><surname>Watanabe</surname><given-names>Y.</given-names></name>
<name><surname>Kido</surname><given-names>T.</given-names></name>
<name><surname>Sakurai</surname><given-names>M.</given-names></name>
<name><surname>Nakagawa</surname><given-names>H.</given-names></name>
<name><surname>Suwazono</surname><given-names>Y.</given-names></name>
</person-group><article-title>Benchmark Dose of Urinary Cadmium for Assessing Renal Tubular and Glomerular Function in a Cadmium-Polluted Area of Japan</article-title><source>Toxics</source><year>2024</year><volume>12</volume><elocation-id>836</elocation-id><pub-id pub-id-type="doi">10.3390/toxics12120836</pub-id><pub-id pub-id-type="pmid">39771051</pub-id>
</element-citation></ref><ref id="B28-toxics-13-00081"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Satarug</surname><given-names>S.</given-names></name>
<name><surname>Vesey</surname><given-names>D.A.</given-names></name>
<name><surname>&#x00110;or&#x00111;evi&#x00107;</surname><given-names>A.B.</given-names></name>
</person-group><article-title>The NOAEL equivalent for the cumulative body burden of cadmium: Focus on proteinuria as an endpoint</article-title><source>J. Environ. Expo. Assess.</source><year>2024</year><volume>3</volume><fpage>26</fpage><pub-id pub-id-type="doi">10.20517/jeea.2024.31</pub-id></element-citation></ref><ref id="B29-toxics-13-00081"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Keefe</surname><given-names>J.A.</given-names></name>
<name><surname>Hwang</surname><given-names>S.J.</given-names></name>
<name><surname>Huan</surname><given-names>T.</given-names></name>
<name><surname>Mendelson</surname><given-names>M.</given-names></name>
<name><surname>Yao</surname><given-names>C.</given-names></name>
<name><surname>Courchesne</surname><given-names>P.</given-names></name>
<name><surname>Saleh</surname><given-names>M.A.</given-names></name>
<name><surname>Madhur</surname><given-names>M.S.</given-names></name>
<name><surname>Levy</surname><given-names>D.</given-names></name>
</person-group><article-title>Evidence for a causal role of the SH2B3-&#x003b2;2M axis in blood pressure regulation</article-title><source>Hypertension</source><year>2019</year><volume>73</volume><fpage>497</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.118.12094</pub-id><pub-id pub-id-type="pmid">30624993</pub-id>
</element-citation></ref><ref id="B30-toxics-13-00081"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mashima</surname><given-names>Y.</given-names></name>
<name><surname>Konta</surname><given-names>T.</given-names></name>
<name><surname>Kudo</surname><given-names>K.</given-names></name>
<name><surname>Takasaki</surname><given-names>S.</given-names></name>
<name><surname>Ichikawa</surname><given-names>K.</given-names></name>
<name><surname>Suzuki</surname><given-names>K.</given-names></name>
<name><surname>Shibata</surname><given-names>Y.</given-names></name>
<name><surname>Watanabe</surname><given-names>T.</given-names></name>
<name><surname>Kato</surname><given-names>T.</given-names></name>
<name><surname>Kawata</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Increases in urinary albumin and beta2-microglobulin are independently associated with blood pressure in the Japanese general population: The Takahata Study</article-title><source>Hypertens. Res.</source><year>2011</year><volume>34</volume><fpage>831</fpage><lpage>835</lpage><pub-id pub-id-type="doi">10.1038/hr.2011.42</pub-id><pub-id pub-id-type="pmid">21525950</pub-id>
</element-citation></ref><ref id="B31-toxics-13-00081"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kudo</surname><given-names>K.</given-names></name>
<name><surname>Konta</surname><given-names>T.</given-names></name>
<name><surname>Mashima</surname><given-names>Y.</given-names></name>
<name><surname>Ichikawa</surname><given-names>K.</given-names></name>
<name><surname>Takasaki</surname><given-names>S.</given-names></name>
<name><surname>Ikeda</surname><given-names>A.</given-names></name>
<name><surname>Hoshikawa</surname><given-names>M.</given-names></name>
<name><surname>Suzuki</surname><given-names>K.</given-names></name>
<name><surname>Shibata</surname><given-names>Y.</given-names></name>
<name><surname>Watanabe</surname><given-names>T.</given-names></name>
<etal/>
</person-group><article-title>The association between renal tubular damage and rapid renal deterioration in the Japanese population: The Takahata study</article-title><source>Clin. Exp. Nephrol.</source><year>2011</year><volume>15</volume><fpage>235</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1007/s10157-010-0392-y</pub-id><pub-id pub-id-type="pmid">21225309</pub-id>
</element-citation></ref><ref id="B32-toxics-13-00081"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Satarug</surname><given-names>S.</given-names></name>
<name><surname>Vesey</surname><given-names>D.A.</given-names></name>
<name><surname>Nishijo</surname><given-names>M.</given-names></name>
<name><surname>Ruangyuttikarn</surname><given-names>W.</given-names></name>
<name><surname>Gobe</surname><given-names>G.C.</given-names></name>
</person-group><article-title>The inverse association of glomerular function and urinary &#x003b2;2-MG excretion and its implications for cadmium health risk assessment</article-title><source>Environ. Res.</source><year>2019</year><volume>173</volume><fpage>40</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.envres.2019.03.026</pub-id><pub-id pub-id-type="pmid">30889420</pub-id>
</element-citation></ref><ref id="B33-toxics-13-00081"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ren</surname><given-names>F.</given-names></name>
<name><surname>Li</surname><given-names>M.</given-names></name>
<name><surname>Xu</surname><given-names>H.</given-names></name>
<name><surname>Qin</surname><given-names>X.</given-names></name>
<name><surname>Teng</surname><given-names>Y.</given-names></name>
</person-group><article-title>Urine albumin-to-creatinine ratio within the normal range and risk of hypertension in the general population: A meta-analysis</article-title><source>J. Clin. Hypertens.</source><year>2021</year><volume>23</volume><fpage>1284</fpage><lpage>1290</lpage><pub-id pub-id-type="doi">10.1111/jch.14263</pub-id><pub-id pub-id-type="pmid">34089300</pub-id>
</element-citation></ref><ref id="B34-toxics-13-00081"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Romero-Gonz&#x000e1;lez</surname><given-names>G.</given-names></name>
<name><surname>Rodr&#x000ed;guez-Chitiva</surname><given-names>N.</given-names></name>
<name><surname>Ca&#x000f1;ameras</surname><given-names>C.</given-names></name>
<name><surname>Pa&#x000fa;l-Mart&#x000ed;nez</surname><given-names>J.</given-names></name>
<name><surname>Urrutia-Jou</surname><given-names>M.</given-names></name>
<name><surname>Troya</surname><given-names>M.</given-names></name>
<name><surname>Soler-Majoral</surname><given-names>J.</given-names></name>
<name><surname>Graterol Torres</surname><given-names>F.</given-names></name>
<name><surname>S&#x000e1;nchez-Bay&#x000e1;</surname><given-names>M.</given-names></name>
<name><surname>Calabia</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Albuminuria, Forgotten No More: Underlining the Emerging Role in CardioRenal Crosstalk</article-title><source>J. Clin. Med.</source><year>2024</year><volume>13</volume><elocation-id>777</elocation-id><pub-id pub-id-type="doi">10.3390/jcm13030777</pub-id><pub-id pub-id-type="pmid">38337471</pub-id>
</element-citation></ref><ref id="B35-toxics-13-00081"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McGill</surname><given-names>J.B.</given-names></name>
<name><surname>Haller</surname><given-names>H.</given-names></name>
<name><surname>Roy-Chaudhury</surname><given-names>P.</given-names></name>
<name><surname>Cherrington</surname><given-names>A.</given-names></name>
<name><surname>Wada</surname><given-names>T.</given-names></name>
<name><surname>Wanner</surname><given-names>C.</given-names></name>
<name><surname>Ji</surname><given-names>L.</given-names></name>
<name><surname>Rossing</surname><given-names>P.</given-names></name>
</person-group><article-title>Making an impact on kidney disease in people with type 2 diabetes: The importance of screening for albuminuria</article-title><source>BMJ Open Diabetes Res. Care</source><year>2022</year><volume>10</volume><fpage>e002806</fpage><pub-id pub-id-type="doi">10.1136/bmjdrc-2022-002806</pub-id><pub-id pub-id-type="pmid">35790319</pub-id>
</element-citation></ref><ref id="B36-toxics-13-00081"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Okubo</surname><given-names>A.</given-names></name>
<name><surname>Nakashima</surname><given-names>A.</given-names></name>
<name><surname>Doi</surname><given-names>S.</given-names></name>
<name><surname>Doi</surname><given-names>T.</given-names></name>
<name><surname>Ueno</surname><given-names>T.</given-names></name>
<name><surname>Maeda</surname><given-names>K.</given-names></name>
<name><surname>Tamura</surname><given-names>R.</given-names></name>
<name><surname>Yamane</surname><given-names>K.</given-names></name>
<name><surname>Masaki</surname><given-names>T.</given-names></name>
</person-group><article-title>High-normal albuminuria is strongly associated with incident chronic kidney disease in a nondiabetic population with normal range of albuminuria and normal kidney function</article-title><source>Clin. Exp. Nephrol.</source><year>2020</year><volume>24</volume><fpage>435</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1007/s10157-019-01842-2</pub-id><pub-id pub-id-type="pmid">32076888</pub-id>
</element-citation></ref><ref id="B37-toxics-13-00081"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lin</surname><given-names>X.</given-names></name>
<name><surname>Song</surname><given-names>W.</given-names></name>
<name><surname>Zhou</surname><given-names>Y.</given-names></name>
<name><surname>Gao</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>Y.</given-names></name>
<name><surname>Deng</surname><given-names>L.</given-names></name>
<name><surname>Liao</surname><given-names>Y.</given-names></name>
<name><surname>Wu</surname><given-names>B.</given-names></name>
<etal/>
</person-group><article-title>Elevated urine albumin creatinine ratio increases cardiovascular mortality in coronary artery disease patients with or without type 2 diabetes mellitus: A multicenter retrospective study</article-title><source>Cardiovasc. Diabetol.</source><year>2023</year><volume>22</volume><fpage>203</fpage><pub-id pub-id-type="doi">10.1186/s12933-023-01907-3</pub-id><pub-id pub-id-type="pmid">37563647</pub-id>
</element-citation></ref><ref id="B38-toxics-13-00081"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Satarug</surname><given-names>S.</given-names></name>
<name><surname>Swaddiwudhipong</surname><given-names>W.</given-names></name>
<name><surname>Ruangyuttikarn</surname><given-names>W.</given-names></name>
<name><surname>Nishijo</surname><given-names>M.</given-names></name>
<name><surname>Ruiz</surname><given-names>P.</given-names></name>
</person-group><article-title>Modeling cadmium exposures in low- and high-exposure areas in Thailand</article-title><source>Environ. Health Perspect.</source><year>2013</year><volume>121</volume><fpage>531</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.1289/ehp.1104769</pub-id><pub-id pub-id-type="pmid">23434727</pub-id>
</element-citation></ref><ref id="B39-toxics-13-00081"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yimthiang</surname><given-names>S.</given-names></name>
<name><surname>Pouyfung</surname><given-names>P.</given-names></name>
<name><surname>Khamphaya</surname><given-names>T.</given-names></name>
<name><surname>Kuraeiad</surname><given-names>S.</given-names></name>
<name><surname>Wongrith</surname><given-names>P.</given-names></name>
<name><surname>Vesey</surname><given-names>D.A.</given-names></name>
<name><surname>Gobe</surname><given-names>G.C.</given-names></name>
<name><surname>Satarug</surname><given-names>S.</given-names></name>
</person-group><article-title>Effects of Environmental Exposure to Cadmium and Lead on the Risks of Diabetes and Kidney Dysfunction</article-title><source>Int. J. Environ. Res. Public Health</source><year>2022</year><volume>19</volume><elocation-id>2259</elocation-id><pub-id pub-id-type="doi">10.3390/ijerph19042259</pub-id><pub-id pub-id-type="pmid">35206446</pub-id>
</element-citation></ref><ref id="B40-toxics-13-00081"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zarcinas</surname><given-names>B.A.</given-names></name>
<name><surname>Pongsakul</surname><given-names>P.</given-names></name>
<name><surname>McLaughlin</surname><given-names>M.J.</given-names></name>
<name><surname>Cozens</surname><given-names>G.</given-names></name>
</person-group><article-title>Heavy metals in soils and crops in Southeast Asia. 2. Thailand</article-title><source>Environ. Geochem. Health</source><year>2004</year><volume>26</volume><fpage>359</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1007/s10653-005-4670-7</pub-id><pub-id pub-id-type="pmid">15719159</pub-id>
</element-citation></ref><ref id="B41-toxics-13-00081"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sripaoraya</surname><given-names>K.</given-names></name>
<name><surname>Siriwong</surname><given-names>W.</given-names></name>
<name><surname>Pavittranon</surname><given-names>S.</given-names></name>
<name><surname>Chapman</surname><given-names>R.S.</given-names></name>
</person-group><article-title>Environmental arsenic exposure and risk of diabetes type 2 in Ron Phibun subdistrict, Nakhon Si Thammarat Province, Thailand: Unmatched and matched case-control studies</article-title><source>Risk Manag Healthc. Policy</source><year>2017</year><volume>10</volume><fpage>41</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.2147/RMHP.S128277</pub-id><pub-id pub-id-type="pmid">28442938</pub-id>
</element-citation></ref><ref id="B42-toxics-13-00081"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Suwatvitayakorn</surname><given-names>P.</given-names></name>
<name><surname>Ko</surname><given-names>M.S.</given-names></name>
<name><surname>Kim</surname><given-names>K.W.</given-names></name>
<name><surname>Chanpiwat</surname><given-names>P.</given-names></name>
</person-group><article-title>Human health risk assessment of cadmium exposure through rice consumption in cadmium-contaminated areas of the Mae Tao sub-district, Tak, Thailand</article-title><source>Environ. Geochem. Health</source><year>2020</year><volume>42</volume><fpage>2331</fpage><lpage>2344</lpage><pub-id pub-id-type="doi">10.1007/s10653-019-00410-7</pub-id><pub-id pub-id-type="pmid">31502116</pub-id>
</element-citation></ref><ref id="B43-toxics-13-00081"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Swaddiwudhipong</surname><given-names>W.</given-names></name>
<name><surname>Mahasakpan</surname><given-names>P.</given-names></name>
<name><surname>Limpatanachote</surname><given-names>P.</given-names></name>
<name><surname>Krintratun</surname><given-names>S.</given-names></name>
</person-group><article-title>Correlations of urinary cadmium with hypertension and diabetes in persons living in cadmium-contaminated villages in northwestern Thailand: A population study</article-title><source>Environ. Res.</source><year>2010</year><volume>110</volume><fpage>612</fpage><lpage>616</lpage><pub-id pub-id-type="doi">10.1016/j.envres.2010.06.002</pub-id><pub-id pub-id-type="pmid">20561611</pub-id>
</element-citation></ref><ref id="B44-toxics-13-00081"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Levey</surname><given-names>A.S.</given-names></name>
<name><surname>Stevens</surname><given-names>L.A.</given-names></name>
<name><surname>Scmid</surname><given-names>C.H.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Castro</surname><given-names>A.F.</given-names><suffix>III</suffix></name>
<name><surname>Feldman</surname><given-names>H.I.</given-names></name>
<name><surname>Kusek</surname><given-names>J.W.</given-names></name>
<name><surname>Eggers</surname><given-names>P.</given-names></name>
<name><surname>Van Lente</surname><given-names>F.</given-names></name>
<name><surname>Greene</surname><given-names>T.</given-names></name>
<etal/>
</person-group><article-title>A new equation to estimate glomerular filtration rate</article-title><source>Ann. Intern. Med.</source><year>2009</year><volume>150</volume><fpage>604</fpage><lpage>612</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-150-9-200905050-00006</pub-id><pub-id pub-id-type="pmid">19414839</pub-id>
</element-citation></ref><ref id="B45-toxics-13-00081"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Levey</surname><given-names>A.S.</given-names></name>
<name><surname>Becker</surname><given-names>C.</given-names></name>
<name><surname>Inker</surname><given-names>L.A.</given-names></name>
</person-group><article-title>Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: A systematic review</article-title><source>JAMA</source><year>2015</year><volume>313</volume><fpage>837</fpage><lpage>846</lpage><pub-id pub-id-type="doi">10.1001/jama.2015.0602</pub-id><pub-id pub-id-type="pmid">25710660</pub-id>
</element-citation></ref><ref id="B46-toxics-13-00081"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>White</surname><given-names>C.A.</given-names></name>
<name><surname>Allen</surname><given-names>C.M.</given-names></name>
<name><surname>Akbari</surname><given-names>A.</given-names></name>
<name><surname>Collier</surname><given-names>C.P.</given-names></name>
<name><surname>Holland</surname><given-names>D.C.</given-names></name>
<name><surname>Day</surname><given-names>A.G.</given-names></name>
<name><surname>Knoll</surname><given-names>G.A.</given-names></name>
</person-group><article-title>Comparison of the new and traditional CKD-EPI GFR estimation equations with urinary inulin clearance: A study of equation performance</article-title><source>Clin. Chim. Acta</source><year>2019</year><volume>488</volume><fpage>189</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1016/j.cca.2018.11.019</pub-id><pub-id pub-id-type="pmid">30445029</pub-id>
</element-citation></ref><ref id="B47-toxics-13-00081"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Phelps</surname><given-names>K.R.</given-names></name>
<name><surname>Gosmanova</surname><given-names>E.O.</given-names></name>
</person-group><article-title>A generic method for analysis of plasma concentrations</article-title><source>Clin. Nephrol.</source><year>2020</year><volume>94</volume><fpage>43</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.5414/CN110056</pub-id><pub-id pub-id-type="pmid">32383639</pub-id>
</element-citation></ref><ref id="B48-toxics-13-00081"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Grandjean</surname><given-names>P.</given-names></name>
<name><surname>Budtz-J&#x000f8;rgensen</surname><given-names>E.</given-names></name>
</person-group><article-title>Total imprecision of exposure biomarkers: Implications for calculating exposure limits</article-title><source>Am. J. Ind. Med.</source><year>2007</year><volume>50</volume><fpage>712</fpage><lpage>719</lpage><pub-id pub-id-type="doi">10.1002/ajim.20474</pub-id><pub-id pub-id-type="pmid">17492658</pub-id>
</element-citation></ref><ref id="B49-toxics-13-00081"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Satarug</surname><given-names>S.</given-names></name>
</person-group><article-title>Is Chronic Kidney Disease Due to Cadmium Exposure Inevitable and Can It Be Reversed?</article-title><source>Biomedicines</source><year>2024</year><volume>12</volume><elocation-id>718</elocation-id><pub-id pub-id-type="doi">10.3390/biomedicines12040718</pub-id><pub-id pub-id-type="pmid">38672074</pub-id>
</element-citation></ref><ref id="B50-toxics-13-00081"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>MacKinnon</surname><given-names>D.P.</given-names></name>
<name><surname>Warsi</surname><given-names>G.</given-names></name>
<name><surname>Dwyer</surname><given-names>J.H.</given-names></name>
</person-group><article-title>A simulation study of mediated effect measures</article-title><source>Multiv. Behav. Res.</source><year>1995</year><volume>30</volume><fpage>41</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1207/s15327906mbr3001_3</pub-id></element-citation></ref><ref id="B51-toxics-13-00081"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Preacher</surname><given-names>K.J.</given-names></name>
<name><surname>Hayes</surname><given-names>A.F.</given-names></name>
</person-group><article-title>SPSS and SAS procedures for estimating indirect effects in simple mediation models</article-title><source>Behav. Res. Meth. Instrum. Comput.</source><year>2004</year><volume>36</volume><fpage>717</fpage><lpage>731</lpage><pub-id pub-id-type="doi">10.3758/BF03206553</pub-id></element-citation></ref><ref id="B52-toxics-13-00081"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Preacher</surname><given-names>K.J.</given-names></name>
</person-group><article-title>Advances in mediation analysis: A survey and synthesis of new developments</article-title><source>Annu. Rev. Psychol.</source><year>2015</year><volume>66</volume><fpage>825</fpage><lpage>852</lpage><pub-id pub-id-type="doi">10.1146/annurev-psych-010814-015258</pub-id><pub-id pub-id-type="pmid">25148853</pub-id>
</element-citation></ref><ref id="B53-toxics-13-00081"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shi</surname><given-names>P.</given-names></name>
<name><surname>Yan</surname><given-names>H.</given-names></name>
<name><surname>Fan</surname><given-names>X.</given-names></name>
<name><surname>Xi</surname><given-names>S.</given-names></name>
</person-group><article-title>A benchmark dose analysis for urinary cadmium and type 2 diabetes mellitus</article-title><source>Environ. Pollut.</source><year>2021</year><volume>273</volume><fpage>116519</fpage><pub-id pub-id-type="doi">10.1016/j.envpol.2021.116519</pub-id><pub-id pub-id-type="pmid">33493762</pub-id>
</element-citation></ref><ref id="B54-toxics-13-00081"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>J.</given-names></name>
<name><surname>Oh</surname><given-names>S.</given-names></name>
<name><surname>Kang</surname><given-names>H.</given-names></name>
<name><surname>Kim</surname><given-names>S.</given-names></name>
<name><surname>Lee</surname><given-names>G.</given-names></name>
<name><surname>Li</surname><given-names>L.</given-names></name>
<name><surname>Kim</surname><given-names>C.T.</given-names></name>
<name><surname>An</surname><given-names>J.N.</given-names></name>
<name><surname>Oh</surname><given-names>Y.K.</given-names></name>
<name><surname>Lim</surname><given-names>C.S.</given-names></name>
<etal/>
</person-group><article-title>Environment-wide association study of CKD</article-title><source>Clin. J. Am. Soc. Nephrol.</source><year>2020</year><volume>15</volume><fpage>766</fpage><lpage>775</lpage><pub-id pub-id-type="doi">10.2215/CJN.06780619</pub-id><pub-id pub-id-type="pmid">32628126</pub-id>
</element-citation></ref><ref id="B55-toxics-13-00081"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tsai</surname><given-names>K.-F.</given-names></name>
<name><surname>Hsu</surname><given-names>P.-C.</given-names></name>
<name><surname>Lee</surname><given-names>C.-T.</given-names></name>
<name><surname>Kung</surname><given-names>C.-T.</given-names></name>
<name><surname>Chang</surname><given-names>Y.-C.</given-names></name>
<name><surname>Fu</surname><given-names>L.-M.</given-names></name>
<name><surname>Ou</surname><given-names>Y.-C.</given-names></name>
<name><surname>Lan</surname><given-names>K.-C.</given-names></name>
<name><surname>Yen</surname><given-names>T.-H.</given-names></name>
<name><surname>Lee</surname><given-names>W.-C.</given-names></name>
</person-group><article-title>Association between Enzyme-Linked Immunosorbent Assay-Measured Kidney Injury Markers and Urinary Cadmium Levels in Chronic Kidney Disease</article-title><source>J. Clin. Med.</source><year>2022</year><volume>11</volume><elocation-id>156</elocation-id><pub-id pub-id-type="doi">10.3390/jcm11010156</pub-id></element-citation></ref><ref id="B56-toxics-13-00081"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Satarug</surname><given-names>S.</given-names></name>
<name><surname>Vesey</surname><given-names>D.A.</given-names></name>
<name><surname>Yimthiang</surname><given-names>S.</given-names></name>
<name><surname>Khamphaya</surname><given-names>T.</given-names></name>
<name><surname>Pouyfung</surname><given-names>P.</given-names></name>
<name><surname>&#x00110;or&#x00111;evi&#x00107;</surname><given-names>A.B.</given-names></name>
</person-group><article-title>Environmental Cadmium Exposure Induces an Increase in Systolic Blood Pressure by Its Effect on GFR</article-title><source>Stresses</source><year>2024</year><volume>4</volume><fpage>436</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.3390/stresses4030029</pub-id></element-citation></ref><ref id="B57-toxics-13-00081"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ikeme</surname><given-names>J.C.</given-names></name>
<name><surname>Katz</surname><given-names>R.</given-names></name>
<name><surname>Muiru</surname><given-names>A.N.</given-names></name>
<name><surname>Estrella</surname><given-names>M.M.</given-names></name>
<name><surname>Scherzer</surname><given-names>R.</given-names></name>
<name><surname>Garimella</surname><given-names>P.S.</given-names></name>
<name><surname>Hallan</surname><given-names>S.I.</given-names></name>
<name><surname>Peralta</surname><given-names>C.A.</given-names></name>
<name><surname>Ix</surname><given-names>J.H.</given-names></name>
<name><surname>Shlipak</surname><given-names>M.G.</given-names></name>
</person-group><article-title>Clinical Risk Factors For Kidney Tubule Biomarker Abnormalities Among Hypertensive Adults With Reduced eGFR in the SPRINT Trial</article-title><source>Am. J. Hypertens.</source><year>2022</year><volume>35</volume><fpage>1006</fpage><lpage>1013</lpage><pub-id pub-id-type="doi">10.1093/ajh/hpac102</pub-id><pub-id pub-id-type="pmid">36094158</pub-id>
</element-citation></ref><ref id="B58-toxics-13-00081"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reckelhoff</surname><given-names>J.F.</given-names></name>
</person-group><article-title>Gender differences in the regulation of blood pressure</article-title><source>Hypertension</source><year>2001</year><volume>37</volume><fpage>1199</fpage><lpage>1208</lpage><pub-id pub-id-type="doi">10.1161/01.HYP.37.5.1199</pub-id><pub-id pub-id-type="pmid">11358929</pub-id>
</element-citation></ref><ref id="B59-toxics-13-00081"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reckelhoff</surname><given-names>J.F.</given-names></name>
</person-group><article-title>Mechanisms of sex and gender differences in hypertension</article-title><source>J. Hum. Hypertens.</source><year>2023</year><volume>37</volume><fpage>596</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1038/s41371-023-00810-4</pub-id><pub-id pub-id-type="pmid">36797338</pub-id>
</element-citation></ref><ref id="B60-toxics-13-00081"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Connelly</surname><given-names>P.J.</given-names></name>
<name><surname>Currie</surname><given-names>G.</given-names></name>
<name><surname>Delles</surname><given-names>C.</given-names></name>
</person-group><article-title>Sex differences in the prevalence, outcomes and management of hypertension</article-title><source>Curr. Hypertens. Rep.</source><year>2022</year><volume>24</volume><fpage>185</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1007/s11906-022-01183-8</pub-id><pub-id pub-id-type="pmid">35254589</pub-id>
</element-citation></ref><ref id="B61-toxics-13-00081"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nagata</surname><given-names>C.</given-names></name>
<name><surname>Nagao</surname><given-names>Y.</given-names></name>
<name><surname>Shibuya</surname><given-names>C.</given-names></name>
<name><surname>Kashiki</surname><given-names>Y.</given-names></name>
<name><surname>Shimizu</surname><given-names>H.</given-names></name>
</person-group><article-title>Urinary cadmium and serum levels of estrogens and androgens in postmenopausal Japanese women</article-title><source>Cancer Epidemiol. Biomarkers Prev.</source><year>2005</year><volume>14</volume><fpage>705</fpage><lpage>708</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-04-0619</pub-id><pub-id pub-id-type="pmid">15767353</pub-id>
</element-citation></ref><ref id="B62-toxics-13-00081"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nagata</surname><given-names>C.</given-names></name>
<name><surname>Konishi</surname><given-names>K.</given-names></name>
<name><surname>Goto</surname><given-names>Y.</given-names></name>
<name><surname>Tamura</surname><given-names>T.</given-names></name>
<name><surname>Wada</surname><given-names>K.</given-names></name>
<name><surname>Hayashi</surname><given-names>M.</given-names></name>
<name><surname>Takeda</surname><given-names>N.</given-names></name>
<name><surname>Yasuda</surname><given-names>K.</given-names></name>
</person-group><article-title>Associations of urinary cadmium with circulating sex hormone levels in pre- and postmenopausal Japanese women</article-title><source>Environ. Res.</source><year>2016</year><volume>150</volume><fpage>82</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1016/j.envres.2016.05.031</pub-id><pub-id pub-id-type="pmid">27268972</pub-id>
</element-citation></ref><ref id="B63-toxics-13-00081"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ali</surname><given-names>I.</given-names></name>
<name><surname>Engstr&#x000f6;m</surname><given-names>A.</given-names></name>
<name><surname>Vahter</surname><given-names>M.</given-names></name>
<name><surname>Skerfving</surname><given-names>S.</given-names></name>
<name><surname>Lundh</surname><given-names>T.</given-names></name>
<name><surname>Lidfeldt</surname><given-names>J.</given-names></name>
<name><surname>Samsioe</surname><given-names>G.</given-names></name>
<name><surname>Halldin</surname><given-names>K.</given-names></name>
<name><surname>&#x000c5;kesson</surname><given-names>A.</given-names></name>
</person-group><article-title>Associations between cadmium exposure and circulating levels of sex hormones in postmenopausal women</article-title><source>Environ. Res.</source><year>2014</year><volume>134</volume><fpage>265</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1016/j.envres.2014.08.009</pub-id><pub-id pub-id-type="pmid">25173093</pub-id>
</element-citation></ref><ref id="B64-toxics-13-00081"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bochud</surname><given-names>M.</given-names></name>
<name><surname>Jenny-Burri</surname><given-names>J.</given-names></name>
<name><surname>Pruijm</surname><given-names>M.</given-names></name>
<name><surname>Ponte</surname><given-names>B.</given-names></name>
<name><surname>Guessous</surname><given-names>I.</given-names></name>
<name><surname>Ehret</surname><given-names>G.</given-names></name>
<name><surname>Petrovic</surname><given-names>D.</given-names></name>
<name><surname>Dudler</surname><given-names>V.</given-names></name>
<name><surname>Haldimann</surname><given-names>M.</given-names></name>
<name><surname>Escher</surname><given-names>G.</given-names></name>
<etal/>
</person-group><article-title>Urinary Cadmium Excretion Is Associated with Increased Synthesis of Cortico- and Sex Steroids in a Population Study</article-title><source>J. Clin. Endocrinol. Metab.</source><year>2018</year><volume>103</volume><fpage>748</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1210/jc.2017-01540</pub-id><pub-id pub-id-type="pmid">29077874</pub-id>
</element-citation></ref><ref id="B65-toxics-13-00081"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hagedoorn</surname><given-names>I.J.M.</given-names></name>
<name><surname>Gant</surname><given-names>C.M.</given-names></name>
<name><surname>Huizen</surname><given-names>S.V.</given-names></name>
<name><surname>Maatman</surname><given-names>R.G.H.J.</given-names></name>
<name><surname>Navis</surname><given-names>G.</given-names></name>
<name><surname>Bakker</surname><given-names>S.J.L.</given-names></name>
<name><surname>Laverman</surname><given-names>G.D.</given-names></name>
</person-group><article-title>Lifestyle-related exposure to cadmium and lead is associated with diabetic kidney disease</article-title><source>J. Clin. Med.</source><year>2020</year><volume>9</volume><elocation-id>2432</elocation-id><pub-id pub-id-type="doi">10.3390/jcm9082432</pub-id><pub-id pub-id-type="pmid">32751456</pub-id>
</element-citation></ref><ref id="B66-toxics-13-00081"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Oosterwijk</surname><given-names>M.M.</given-names></name>
<name><surname>Hagedoorn</surname><given-names>I.J.M.</given-names></name>
<name><surname>Maatman</surname><given-names>R.G.H.J.</given-names></name>
<name><surname>Bakker</surname><given-names>S.J.L.</given-names></name>
<name><surname>Navis</surname><given-names>G.</given-names></name>
<name><surname>Laverman</surname><given-names>G.D.</given-names></name>
</person-group><article-title>Cadmium, active smoking and renal function deterioration in patients with type 2 diabetes</article-title><source>Nephrol. Dial. Transplant.</source><year>2023</year><volume>38</volume><fpage>876</fpage><lpage>883</lpage><pub-id pub-id-type="doi">10.1093/ndt/gfac270</pub-id><pub-id pub-id-type="pmid">36124748</pub-id>
</element-citation></ref></ref-list><sec sec-type="display-objects"><title>Figures, Scheme and Tables</title><fig position="float" id="toxics-13-00081-sch001"><object-id pub-id-type="pii">toxics-13-00081-sch001_Scheme 1</object-id><label>Scheme 1</label><caption><p>A model with M as a mediator of an effect of X on Y.</p></caption><graphic xlink:href="toxics-13-00081-sch001" position="float"/></fig><fig position="float" id="toxics-13-00081-f001"><label>Figure 1</label><caption><p>Dose&#x02013;response relationship of albumin excretion rate, cadmium excretion rate, and blood pressure. Scatterplots relate log[(E<sub>alb</sub>/C<sub>cr</sub>) &#x000d7; 10<sup>4</sup>) to log[(E<sub>Cd</sub>/C<sub>cr</sub>) &#x000d7; 105] in women and men who had low- (<bold>a</bold>) and high-Cd burden (<bold>b</bold>). Scatterplots relate log[(E<sub>alb</sub>/C<sub>cr</sub>) &#x000d7; 10<sup>4</sup>] to systolic blood pressure (<bold>c</bold>) and diastolic blood pressure (<bold>d</bold>) in women and men with low- or high-Cd burdens. Coefficients of determination (R<sup>2</sup>) and <italic toggle="yes">p</italic>-values and numbers of subjects are provided. The low- and high-Cd burdens were defined as E<sub>Cd</sub>/C<sub>cr</sub> &#x0003c; 0.01 and &#x02265;0.01 &#x000b5;g/L filtrate, respectively.</p></caption><graphic xlink:href="toxics-13-00081-g001" position="float"/></fig><fig position="float" id="toxics-13-00081-f002"><label>Figure 2</label><caption><p>Quantification of the effects of blood pressure and eGFR levels on the albumin excretion rate. Scatterplots relate log[(E<sub>alb</sub>/C<sub>cr</sub>) &#x000d7; 10<sup>4</sup>] to SBP (<bold>a</bold>) and DBP (<bold>b</bold>) in subjects with eGFR &#x02264; 60, 61&#x02013;90, and &#x02265;90 mL/min/1.73 m<sup>2</sup>. Coefficients of determination (R<sup>2</sup>), <italic toggle="yes">p</italic>-values, and numbers of subjects are provided. Bar graphs represent the mean log[(E<sub>alb</sub>/C<sub>cr</sub>) &#x000d7; 10<sup>4</sup>] in eGFR subgroups with SBP &#x02265; 130 mmHg (<bold>c</bold>) and DBP &#x02265; 80 mmHg (<bold>d</bold>). SBP of 130 mmHg and DBP 80 mmHg were the median SBP and DBP values, respectively. All means were adjusted for covariates (age, BMI, E<sub>Cd</sub>/C<sub>cr</sub>) and the interaction of smoking &#x000d7; hypertension &#x000d7; diabetes.</p></caption><graphic xlink:href="toxics-13-00081-g002" position="float"/></fig><fig position="float" id="toxics-13-00081-f003"><label>Figure 3</label><caption><p>Analysis of the mediating effects of cadmium in systolic and diastolic blood pressure. A model depicts eGFR as the mediator of rising systolic blood pressure (<bold>a</bold>) and rising diastolic blood pressure (<bold>b</bold>); the Sobel test for an indirect effect of Cd on SBP (<bold>c</bold>) and DBP (<bold>d</bold>).</p></caption><graphic xlink:href="toxics-13-00081-g003" position="float"/></fig><fig position="float" id="toxics-13-00081-f004"><label>Figure 4</label><caption><p>Rising systolic blood pressure as the mediator of an elevation of albumin excretion induced by cadmium. A model depicts SBP (<bold>a</bold>) and DBP (<bold>b</bold>) as the mediator of the Cd effect on the albumin excretion rate; the Sobel test for the indirect effect of SBP (<bold>c</bold>) and DBP (<bold>d</bold>) on the albumin excretion rate.</p></caption><graphic xlink:href="toxics-13-00081-g004" position="float"/></fig><table-wrap position="float" id="toxics-13-00081-t001"><object-id pub-id-type="pii">toxics-13-00081-t001_Table 1</object-id><label>Table 1</label><caption><p>Descriptive characteristics of cohort participants according to &#x003b2;<sub>2</sub>-microglobulin excretion rates.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Parameters</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">All<break/><italic toggle="yes">n</italic> = 641</th><th colspan="4" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">E<sub>&#x003b2;2M</sub>/C<sub>cr</sub>, &#x000b5;g/L Filtrate</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003c;1.0, <italic toggle="yes">n</italic> = 442</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.0&#x02013;2.9, <italic toggle="yes">n</italic> = 69</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.0&#x02013;9.9, <italic toggle="yes">n</italic> = 61</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02265;10, <italic toggle="yes">n</italic> = 61</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Age, years</td><td align="center" valign="middle" rowspan="1" colspan="1">47.5 (10.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">44.2 (8.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">51.1 (9.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">55.5 (10.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">58.4 (9.8) ***</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Age range, years</td><td align="center" valign="middle" rowspan="1" colspan="1">16&#x02013;80</td><td align="center" valign="middle" rowspan="1" colspan="1">16&#x02013;69</td><td align="center" valign="middle" rowspan="1" colspan="1">21&#x02013;75</td><td align="center" valign="middle" rowspan="1" colspan="1">31&#x02013;80</td><td align="center" valign="middle" rowspan="1" colspan="1">42&#x02013;79</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">BMI, kg/m<sup>2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">24.4 (4.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">24.2 (3.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">24.7 (5.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">24.8 (4.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">24.8 (4.2)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">% BMI &#x02265; 30 kg/m<sup>2</sup> (obese)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.3</td><td align="center" valign="middle" rowspan="1" colspan="1">5.0</td><td align="center" valign="middle" rowspan="1" colspan="1">10.4</td><td align="center" valign="middle" rowspan="1" colspan="1">7.2</td><td align="center" valign="middle" rowspan="1" colspan="1">10.0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">eGFR <sup>a</sup>, mL/min/1.73 m<sup>2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">95 (19)</td><td align="center" valign="middle" rowspan="1" colspan="1">101 (15)</td><td align="center" valign="middle" rowspan="1" colspan="1">93 (14)</td><td align="center" valign="middle" rowspan="1" colspan="1">83 (16)</td><td align="center" valign="middle" rowspan="1" colspan="1">67 (18) ***</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">% Low eGFR (CKD)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.8</td><td align="center" valign="middle" rowspan="1" colspan="1">0.7</td><td align="center" valign="middle" rowspan="1" colspan="1">1.4</td><td align="center" valign="middle" rowspan="1" colspan="1">5.8</td><td align="center" valign="middle" rowspan="1" colspan="1">37.7 ***</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">% Women</td><td align="center" valign="middle" rowspan="1" colspan="1">66.9</td><td align="center" valign="middle" rowspan="1" colspan="1">63.8</td><td align="center" valign="middle" rowspan="1" colspan="1">71.1</td><td align="center" valign="middle" rowspan="1" colspan="1">72.5</td><td align="center" valign="middle" rowspan="1" colspan="1">78.7</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">% Hypertension</td><td align="center" valign="middle" rowspan="1" colspan="1">39.8</td><td align="center" valign="middle" rowspan="1" colspan="1">34.4</td><td align="center" valign="middle" rowspan="1" colspan="1">42.2</td><td align="center" valign="middle" rowspan="1" colspan="1">52.2</td><td align="center" valign="middle" rowspan="1" colspan="1">62.3 ***</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">% Smoking</td><td align="center" valign="middle" rowspan="1" colspan="1">29.0</td><td align="center" valign="middle" rowspan="1" colspan="1">31.0</td><td align="center" valign="middle" rowspan="1" colspan="1">30.4</td><td align="center" valign="middle" rowspan="1" colspan="1">15.9</td><td align="center" valign="middle" rowspan="1" colspan="1">27.9</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">% Diabetes</td><td align="center" valign="middle" rowspan="1" colspan="1">10.8</td><td align="center" valign="middle" rowspan="1" colspan="1">0.9</td><td align="center" valign="middle" rowspan="1" colspan="1">14.7</td><td align="center" valign="middle" rowspan="1" colspan="1">29.0</td><td align="center" valign="middle" rowspan="1" colspan="1">54.7 ***</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Systolic blood pressure, mmHg</td><td align="center" valign="middle" rowspan="1" colspan="1">126 (16)</td><td align="center" valign="middle" rowspan="1" colspan="1">122 (13)</td><td align="center" valign="middle" rowspan="1" colspan="1">129 (16)</td><td align="center" valign="middle" rowspan="1" colspan="1">135 (18)</td><td align="center" valign="middle" rowspan="1" colspan="1">140 (18) ***</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Diastolic blood pressure, mmHg</td><td align="center" valign="middle" rowspan="1" colspan="1">80 (10)</td><td align="center" valign="middle" rowspan="1" colspan="1">78.4 (9.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">82.8 (10.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">84 (10)</td><td align="center" valign="middle" rowspan="1" colspan="1">84 (9) ***</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Normalized to E<sub>cr</sub> (E<sub>x</sub>/E<sub>cr</sub>)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">E<sub>Cd</sub>/E<sub>cr</sub>, &#x000b5;g/g creatinine</td><td align="center" valign="middle" rowspan="1" colspan="1">2.98 (4.01)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.00 (3.73)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.43 (4.35)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.35 (4.24)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.06 (5.17) ***</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">E<sub>&#x003b2;2M</sub>/E<sub>cr</sub>, &#x000b5;g/g creatinine</td><td align="center" valign="middle" rowspan="1" colspan="1">516 (2153)</td><td align="center" valign="middle" rowspan="1" colspan="1">37 (36)</td><td align="center" valign="middle" rowspan="1" colspan="1">221 (74)</td><td align="center" valign="middle" rowspan="1" colspan="1">697 (274)</td><td align="center" valign="middle" rowspan="1" colspan="1">4124 (5854) ***</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">E<sub>alb</sub>/E<sub>cr</sub>, mg/g creatinine (ACR)</td><td align="center" valign="middle" rowspan="1" colspan="1">22 (65)</td><td align="center" valign="middle" rowspan="1" colspan="1">12 (31)</td><td align="center" valign="middle" rowspan="1" colspan="1">14 (25)</td><td align="center" valign="middle" rowspan="1" colspan="1">22 (51)</td><td align="center" valign="middle" rowspan="1" colspan="1">74 (147) ***</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">% Albuminuria <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">14.9</td><td align="center" valign="middle" rowspan="1" colspan="1">9.4</td><td align="center" valign="middle" rowspan="1" colspan="1">13.3</td><td align="center" valign="middle" rowspan="1" colspan="1">17,2</td><td align="center" valign="middle" rowspan="1" colspan="1">38.3 ***</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Normalized to C<sub>cr</sub>, (E<sub>x</sub>/C<sub>cr</sub>) <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(E<sub>Cd</sub>/C<sub>cr</sub>) &#x000d7; 100, &#x000b5;g/L filtrate</td><td align="center" valign="middle" rowspan="1" colspan="1">2.37 (3.35)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.27 (2.84)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.67 (3.84)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.01 (3.52)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.17 (5.34) **</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(E<sub>&#x003b2;2M</sub>/C<sub>cr</sub>) &#x000d7; 100, &#x000b5;g/L filtrate</td><td align="center" valign="middle" rowspan="1" colspan="1">556 (2857)</td><td align="center" valign="middle" rowspan="1" colspan="1">27 (26)</td><td align="center" valign="middle" rowspan="1" colspan="1">170 (52)</td><td align="center" valign="middle" rowspan="1" colspan="1">587 (204)</td><td align="center" valign="middle" rowspan="1" colspan="1">4789 (8159) ***</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(E<sub>alb</sub>/C<sub>cr</sub>) &#x000d7; 100, &#x000b5;g/L filtrate</td><td align="center" valign="middle" rowspan="1" colspan="1">22 (79)</td><td align="center" valign="middle" rowspan="1" colspan="1">9 (25)</td><td align="center" valign="middle" rowspan="1" colspan="1">11 (22)</td><td align="center" valign="middle" rowspan="1" colspan="1">20 (50)</td><td align="center" valign="middle" rowspan="1" colspan="1">88 (191) ***</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">% (E<sub>alb</sub>/C<sub>cr</sub>) &#x000d7; 100 &#x02265; 20 &#x000b5;g/L filtrate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45.0 ***</td></tr></tbody></table><table-wrap-foot><fn><p><italic toggle="yes">n</italic>, number of subjects; BMI, body mass index; eGFR, estimated glomerular filtration rate; cr, creatinine; alb, albumin; Cd, cadmium; ACR, albumin-to-creatinine ratio. <sup>a</sup> eGFR was determined using equations of the Chronic Kidney Disease Epidemiology Collaboration (CKD&#x02212;EPI). <sup>b</sup> Albuminuria was defined as ACR &#x02265; 20 and &#x02265;30 mg/g creatinine in men and women, respectively. <sup>c</sup> E<sub>Cd</sub>/C<sub>cr</sub> = [Cd]<sub>u</sub>[cr]<sub>p</sub>/[cr]<sub>u</sub>. Data for BMI and urinary albumin were from 617 and 451 subjects, respectively. All other data were from 641 subjects. Continuous variables are expressed as arithmetic mean and standard deviation (SD) values. For all tests, <italic toggle="yes">p</italic> &#x02264; 0.05 identifies statistical significance, determined with the Pearson chi-square test for differences in percentages and the Kruskal&#x02013;Wallis test for differences of means among E<sub>&#x003b2;2M</sub>/Ccr groups. *** <italic toggle="yes">p</italic> &#x0003c; 0.001; ** <italic toggle="yes">p</italic> = 0.003.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="toxics-13-00081-t002"><object-id pub-id-type="pii">toxics-13-00081-t002_Table 2</object-id><label>Table 2</label><caption><p>Prevalence odds ratios for three adverse outcomes in relation to cadmium body burden and other independent variables.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Independent Variables/Factors</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">CKD <sup>a</sup></th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Hypertension</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Tubular Dysfunction <sup>b</sup></th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">POR (95% CI)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">POR (95% CI)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">POR (95% CI)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Age, years</td><td align="center" valign="middle" rowspan="1" colspan="1">1.156 (1.096, 1.218)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">1.059 (1.041, 1.078)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">1.112 (1.075, 1.149)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">BMI, kg/m<sup>2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.027 (0.930, 1.135)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.599</td><td align="center" valign="middle" rowspan="1" colspan="1">1.120 (1.071, 1.171)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">0.962 (0.898, 1.031)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.273</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Log<sub>2</sub>[(E<sub>Cd</sub>/C<sub>cr</sub>) &#x000d7; 10<sup>5</sup>], &#x000b5;g/L filtrate</td><td align="center" valign="middle" rowspan="1" colspan="1">3.517 (1.754, 7.051)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">1.218 (1.124, 1.319)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">1.037 (0.917, 1.173)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.567</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Gender</td><td align="center" valign="middle" rowspan="1" colspan="1">0.532 (0.150, 1.887)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.329</td><td align="center" valign="middle" rowspan="1" colspan="1">1.462 (0.964, 2.215)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.074</td><td align="center" valign="middle" rowspan="1" colspan="1">1.321 (0.617, 2.571)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.413</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Smoking</td><td align="center" valign="middle" rowspan="1" colspan="1">0.708 (0.226, 2.215)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.553</td><td align="center" valign="middle" rowspan="1" colspan="1">1.477 (0.959, 2.274)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.077</td><td align="center" valign="middle" rowspan="1" colspan="1">1.163 (0.585, 2.315)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.667</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Diabetes</td><td align="center" valign="middle" rowspan="1" colspan="1">4.839 (1.725, 13.58)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" rowspan="1" colspan="1">2.008 (1.072, 3.726)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.030</td><td align="center" valign="middle" rowspan="1" colspan="1">16.12 (7.219, 36.02)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Hypertension</td><td align="center" valign="middle" rowspan="1" colspan="1">1.152 (0.497, 2.669)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.742</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" rowspan="1" colspan="1">1.556 (0.924, 2.622)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.097</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CKD <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.877 (0.393, 1.958)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.750</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17.67 (5.155, 60.56)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table><table-wrap-foot><fn><p>CKD, chronic kidney disease; POR, prevalence odds ratio; CI, confidence interval; BMI, body mass index. <sup>a</sup> CKD was defined as eGFR &#x02264; 60 mL/min/1.73 m<sup>2</sup>. <sup>b</sup> Tubular dysfunction was indicated by E<sub>&#x003b2;2M</sub>/C<sub>cr</sub> &#x02265; 3.0 &#x000b5;g/L filtrate. For all tests, <italic toggle="yes">p</italic>-values &#x02264; 0.05 indicate a statistically significant association between an individual independent variable and the POR for CKD, hypertension, or tubular proteinuria.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="toxics-13-00081-t003"><object-id pub-id-type="pii">toxics-13-00081-t003_Table 3</object-id><label>Table 3</label><caption><p>Hypertension as the key determinant of albuminuria.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Independent Variables/Factors</th><th colspan="6" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Albuminuria <sup>a</sup></th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All, <italic toggle="yes">n</italic> = 445</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Normotension, <italic toggle="yes">n</italic> = 229</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypertension, <italic toggle="yes">n</italic> = 216</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">POR (95% CI)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">POR (95% CI)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">POR (95% CI)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Age, years</td><td align="center" valign="middle" rowspan="1" colspan="1">1.000 (0.962, 1.039)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.988</td><td align="center" valign="middle" rowspan="1" colspan="1">1.004 (0.942, 1.069)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.913</td><td align="center" valign="middle" rowspan="1" colspan="1">0.991 (0.940, 1.045)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.739</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Log<sub>2</sub>[(E<sub>Cd</sub>C<sub>cr</sub>) &#x000d7; 10<sup>5</sup>], &#x000b5;g/L filtrate</td><td align="center" valign="middle" rowspan="1" colspan="1">1.042 (0.905, 1.199)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.571</td><td align="center" valign="middle" rowspan="1" colspan="1">0.940 (0.750, 1.179)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.593</td><td align="center" valign="middle" rowspan="1" colspan="1">1.088 (0.894, 1.325)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.401</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Obese</td><td align="center" valign="middle" rowspan="1" colspan="1">1.346 (0.525, 3.453)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.536</td><td align="center" valign="middle" rowspan="1" colspan="1">1.545 (0.277, 8.626)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.620</td><td align="center" valign="middle" rowspan="1" colspan="1">0.930 (0.269, 3.215)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.909</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">CKD</td><td align="center" valign="middle" rowspan="1" colspan="1">3.312 (1.272, 8.623)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.014</td><td align="center" valign="middle" rowspan="1" colspan="1">3.766 (0.626, 22.65)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.147</td><td align="center" valign="middle" rowspan="1" colspan="1">4.293 (1.072, 17.19)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.040</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Diabetes</td><td align="center" valign="middle" rowspan="1" colspan="1">3.603 (1.559, 8.326)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.003</td><td align="center" valign="middle" rowspan="1" colspan="1">1.913 (0.397, 9.216)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.419</td><td align="center" valign="middle" rowspan="1" colspan="1">5.376 (1.795, 16.10)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.003</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Gender</td><td align="center" valign="middle" rowspan="1" colspan="1">1.458 (0.715, 2.972)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.299</td><td align="center" valign="middle" rowspan="1" colspan="1">1.944 (0.690, 5.475)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.208</td><td align="center" valign="middle" rowspan="1" colspan="1">0.869 (0.304, 2.483)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.793</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Smoking</td><td align="center" valign="middle" rowspan="1" colspan="1">0.835 (0.400, 1.743)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.630</td><td align="center" valign="middle" rowspan="1" colspan="1">0.812 (0.274, 2.409)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.708</td><td align="center" valign="middle" rowspan="1" colspan="1">0.776 (0.259, 2.328)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.651</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Tubular dysfunction <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Moderate</td><td align="center" valign="middle" rowspan="1" colspan="1">Referent</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Severe</td><td align="center" valign="middle" rowspan="1" colspan="1">1.827 (0.822, 4.062)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.139</td><td align="center" valign="middle" rowspan="1" colspan="1">0.866 (0.213, 3.517)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.840</td><td align="center" valign="middle" rowspan="1" colspan="1">2.946 (1.038, 8.358)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.042</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Extremely severe</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.428 (0.983, 5.997)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.054</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.655 (0.092, 4.671)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.673</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.167 (1.250, 13.90)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.020</td></tr></tbody></table><table-wrap-foot><fn><p>POR, prevalence odds ratio; CI, confidence interval. <sup>a</sup> Albuminuria was defined as E<sub>alb</sub>/C<sub>cr</sub> &#x02265; 0.2 mg/L filtrate in both men and women. <sup>b</sup> Moderate, severe, and extremely severe dysfunction were indicated by E<sub>&#x003b2;2M</sub>/C<sub>cr</sub> &#x0003c; 3, 3.0&#x02013;9.9, and &#x02265;10 &#x000b5;g/L filtrate. For all tests, <italic toggle="yes">p</italic>-values &#x02264; 0.05 indicate a statistically significant association between an individual independent variable and the POR for albuminuria.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="toxics-13-00081-t004"><object-id pub-id-type="pii">toxics-13-00081-t004_Table 4</object-id><label>Table 4</label><caption><p>Multiple linear regression analysis to define predictors of albumin excretion.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Independent<break/>Variables/Factors</th><th colspan="6" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Log[(E<sub>alb</sub>/C<sub>cr</sub>) &#x000d7; 10<sup>4</sup>], &#x000b5;g/L Filtrate</th></tr><tr><th colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">All, <italic toggle="yes">n</italic> = 451</th><th colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Women, <italic toggle="yes">n</italic> = 336</th><th colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Men, <italic toggle="yes">n</italic> = 115</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Model 1: SBP</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Age, years</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.075</td><td align="center" valign="middle" rowspan="1" colspan="1">0.217</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.047</td><td align="center" valign="middle" rowspan="1" colspan="1">0.502</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.135</td><td align="center" valign="middle" rowspan="1" colspan="1">0.248</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">BMI, kg/m<sup>2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.039</td><td align="center" valign="middle" rowspan="1" colspan="1">0.408</td><td align="center" valign="middle" rowspan="1" colspan="1">0.062</td><td align="center" valign="middle" rowspan="1" colspan="1">0.248</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.042</td><td align="center" valign="middle" rowspan="1" colspan="1">0.664</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">eGFR, mL/min/1.73 m<sup>2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.180</td><td align="center" valign="middle" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.188</td><td align="center" valign="middle" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.174</td><td align="center" valign="middle" rowspan="1" colspan="1">0.090</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Log[(E<sub>Cd</sub>/C<sub>cr</sub>) &#x000d7; 10<sup>5</sup>], &#x000b5;g/L filtrate</td><td align="center" valign="middle" rowspan="1" colspan="1">0.103</td><td align="center" valign="middle" rowspan="1" colspan="1">0.073</td><td align="center" valign="middle" rowspan="1" colspan="1">0.102</td><td align="center" valign="middle" rowspan="1" colspan="1">0.132</td><td align="center" valign="middle" rowspan="1" colspan="1">0.109</td><td align="center" valign="middle" rowspan="1" colspan="1">0.332</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Diabetes</td><td align="center" valign="middle" rowspan="1" colspan="1">0.179</td><td align="center" valign="middle" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">0.141</td><td align="center" valign="middle" rowspan="1" colspan="1">0.023</td><td align="center" valign="middle" rowspan="1" colspan="1">0.285</td><td align="center" valign="middle" rowspan="1" colspan="1">0.007</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Systolic pressure, mmHg</td><td align="center" valign="middle" rowspan="1" colspan="1">0.263</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">0.272</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">0.252</td><td align="center" valign="middle" rowspan="1" colspan="1">0.013</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Gender</td><td align="center" valign="middle" rowspan="1" colspan="1">0.015</td><td align="center" valign="middle" rowspan="1" colspan="1">0.769</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Smoking</td><td align="center" valign="middle" rowspan="1" colspan="1">0.046</td><td align="center" valign="middle" rowspan="1" colspan="1">0.379</td><td align="center" valign="middle" rowspan="1" colspan="1">0.085</td><td align="center" valign="middle" rowspan="1" colspan="1">0.115</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.035</td><td align="center" valign="middle" rowspan="1" colspan="1">0.710</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Adjusted R<sup>2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.147</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">0.143</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">0.146</td><td align="center" valign="middle" rowspan="1" colspan="1">0.001</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Model 2: DBP</italic>
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Age, years</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.006</td><td align="center" valign="middle" rowspan="1" colspan="1">0.921</td><td align="center" valign="middle" rowspan="1" colspan="1">0.028</td><td align="center" valign="middle" rowspan="1" colspan="1">0.695</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.086</td><td align="center" valign="middle" rowspan="1" colspan="1">0.465</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">BMI, kg/m<sup>2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.051</td><td align="center" valign="middle" rowspan="1" colspan="1">0.289</td><td align="center" valign="middle" rowspan="1" colspan="1">0.072</td><td align="center" valign="middle" rowspan="1" colspan="1">0.191</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.026</td><td align="center" valign="middle" rowspan="1" colspan="1">0.797</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">eGFR, mL/min/1.73 m<sup>2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.195</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.201</td><td align="center" valign="middle" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.198</td><td align="center" valign="middle" rowspan="1" colspan="1">0.057</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Log[(E<sub>Cd</sub>/C<sub>cr</sub>) &#x000d7; 10<sup>5</sup>], &#x000b5;g/L filtrate</td><td align="center" valign="middle" rowspan="1" colspan="1">0.122</td><td align="center" valign="middle" rowspan="1" colspan="1">0.039</td><td align="center" valign="middle" rowspan="1" colspan="1">0.119</td><td align="center" valign="middle" rowspan="1" colspan="1">0.085</td><td align="center" valign="middle" rowspan="1" colspan="1">0.128</td><td align="center" valign="middle" rowspan="1" colspan="1">0.265</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Diabetes</td><td align="center" valign="middle" rowspan="1" colspan="1">0.220</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">0.189</td><td align="center" valign="middle" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" rowspan="1" colspan="1">0.306</td><td align="center" valign="middle" rowspan="1" colspan="1">0.005</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Diastolic pressure, mmHg</td><td align="center" valign="middle" rowspan="1" colspan="1">0.150</td><td align="center" valign="middle" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">0.149</td><td align="center" valign="middle" rowspan="1" colspan="1">0.005</td><td align="center" valign="middle" rowspan="1" colspan="1">0.152</td><td align="center" valign="middle" rowspan="1" colspan="1">0.125</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Gender</td><td align="center" valign="middle" rowspan="1" colspan="1">0.011</td><td align="center" valign="middle" rowspan="1" colspan="1">0.839</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Smoking</td><td align="center" valign="middle" rowspan="1" colspan="1">0.032</td><td align="center" valign="middle" rowspan="1" colspan="1">0.547</td><td align="center" valign="middle" rowspan="1" colspan="1">0.068</td><td align="center" valign="middle" rowspan="1" colspan="1">0.214</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.040</td><td align="center" valign="middle" rowspan="1" colspan="1">0.680</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adjusted R<sup>2</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.113</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.105</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.113</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.006</td></tr></tbody></table><table-wrap-foot><fn><p><italic toggle="yes">n</italic>, number of subjects; eGFR, estimated glomerular filtration rate; &#x003b2;, standardized regression coefficient; BMI, body mass index; adjusted R<sup>2</sup>, coefficient of determination. &#x003b2; indicates strength of association of E<sub>alb</sub>/C<sub>cr</sub> with eight independent variables (first column). Adjusted R<sup>2</sup> indicates the proportion of E<sub>alb</sub>/C<sub>cr</sub> variation, by which all independent variables are explained. For all tests, <italic toggle="yes">p</italic>-values &#x02264; 0.05 indicate a statistically significant association of E<sub>alb</sub>/C<sub>cr</sub> with an individual independent variable.</p></fn></table-wrap-foot></table-wrap></sec></back></article>